Username

Password

Forgot Password?

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

Peter Riederer

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Disorders

Anatomy

Chemicals & Drugs

Physiology

Brain Chemistry

Living Beings

Rats

Sign-in to see full Profile

Network (preview)

Co-Publications
Name
123
Gerlach, Manfred
79
Jellinger, Kurt
75
Youdim, Moussa
37
Koutsilieri, Eleni
36
Lesch, Klaus-Peter
35
Sofic, Emin
34
Götz, Mario
34
Beckmann, Helmut
31
Gsell, W
26
Double, Kay
25
Thome, Johannes
22
Sopper, Sieghart
22
Münch, Gerald
22
Grünblatt, Edna
21
ter Meulen, Volker

Sign-in to see all Coauthors

Publications

TOP 3
Naoi Makoto; Yi Hong; Maruyama Wakako; Inaba Keiko; Shamoto-Nagai Masayo; Akao Yukihiro; Gerlach Manfred; Riederer Peter
Glutathione redox status in mitochondria and cytoplasm differentially and sequentially activates apoptosis cascade in dopamine-melanin-treated SH-SY5Y cells.
Lackovic Zdravko; Rebic Veseljka; Riederer Peter F
Single intracerebroventricular injection of botulinum toxin type A produces slow onset and long-term memory impairment in rats.
Grünblatt Edna; Monoranu Camelia Maria; Apfelbacher Manuela; Keller Daniela; Michel Tanja M; Alafuzoff Irina; Ferrer Isidro; Al-Saraj Safa; Keyvani Kathy; Schmitt Andrea; Falkai Peter; Schittenhelm Jens; McLean Catriona; Halliday Glenda M; Harper Clive; Deckert Jürgen; Roggendorf Wolfgang; Riederer Peter
Tryptophan is a marker of human postmortem brain tissue quality.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Peter Riederer (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Naoi Makoto; Yi Hong; Maruyama Wakako; Inaba Keiko; Shamoto-Nagai Masayo; Akao Yukihiro; Gerlach Manfred; Riederer Peter
Glutathione redox status in mitochondria and cytoplasm differentially and sequentially activates apoptosis cascade in dopamine-melanin-treated SH-SY5Y cells.
Neuroscience letters 2009;465(2):118-22.
2009: Lackovic Zdravko; Rebic Veseljka; Riederer Peter F
Single intracerebroventricular injection of botulinum toxin type A produces slow onset and long-term memory impairment in rats.
Journal of neural transmission (Vienna, Austria : 1996) 2009;116(10):1273-80.
2009: Grünblatt Edna; Monoranu Camelia Maria; Apfelbacher Manuela; Keller Daniela; Michel Tanja M; Alafuzoff Irina; Ferrer Isidro; Al-Saraj Safa; Keyvani Kathy; Schmitt Andrea; Falkai Peter; Schittenhelm Jens; McLean Catriona; Halliday Glenda M; Harper Clive; Deckert Jürgen; Roggendorf Wolfgang; Riederer Peter
Tryptophan is a marker of human postmortem brain tissue quality.
Journal of neurochemistry 2009;110(5):1400-8.
2009: Pfuhlmann Bruno; Hiemke Christoph; Unterecker Stephan; Burger Rainer; Schmidtke Armin; Riederer Peter; Deckert Jürgen; Jabs Burkhard
Toxic clozapine serum levels during inflammatory reactions.
Journal of clinical psychopharmacology 2009;29(4):392-4.
2009: Tribl Florian; Asan Esther; Arzberger Thomas; Tatschner Thomas; Langenfeld Elmar; Meyer Helmut E; Bringmann Gerhard; Riederer Peter; Gerlach Manfred; Marcus Katrin
Identification of L-ferritin in neuromelanin granules of the human substantia nigra: a targeted proteomics approach.
Molecular & cellular proteomics : MCP 2009;8(8):1832-8.
2009: Monoranu C M; Apfelbacher M; Grünblatt E; Puppe B; Alafuzoff I; Ferrer I; Al-Saraj S; Keyvani K; Schmitt A; Falkai P; Schittenhelm J; Halliday G; Kril J; Harper C; McLean C; Riederer P; Roggendorf W
pH measurement as quality control on human post mortem brain tissue: a study of the BrainNet Europe consortium.
Neuropathology and applied neurobiology 2009;35(3):329-37.
2009: Double K L; Rowe D B; Carew-Jones F M; Hayes M; Chan D K Y; Blackie J; Corbett A; Joffe R; Fung V S; Morris J; Riederer P; Gerlach M; Halliday G M
Anti-melanin antibodies are increased in sera in Parkinson's disease.
Experimental neurology 2009;217(2):297-301.
2009: Grünblatt Edna; Bartl Jasmin; Zehetmayer Sonja; Ringel Thomas M; Bauer Peter; Riederer Peter; Jacob Christian P
Gene expression as peripheral biomarkers for sporadic Alzheimer's disease.
Journal of Alzheimer's disease : JAD 2009;16(3):627-34.
2009: Grünblatt Edna; Zehetmayer Sonja; Bartl Jasmin; Löffler Christiane; Wichart Ildiko; Rainer Michael K; Jungwirth Susanne; Bauer Peter; Danielczyk Walter; Tragl Karl-Heinz; Riederer Peter; Fischer Peter
Genetic risk factors and markers for Alzheimer's disease and/or depression in the VITA study.
Journal of psychiatric research 2009;43(3):298-308.
2009: Riederer P F
Letter to the editor.
The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry 2009;10(3):254.
2009: Stober Gerald; Ben-Shachar Dorit; Cardon M; Falkai Peter; Fonteh Alfred N; Gawlik Micha; Glenthoj Birte Y; Grunblatt Edna; Jablensky Assen; Kim Yong-Ku; Kornhuber Johannes; McNeil Thomas F; Muller Norbert; Oranje Bob; Saito Toshikazu; Saoud Mohamed; Schmitt Andrea; Schwartz Michal; Thome Johannes; Uzbekov Marat; Durany Nuria; Riederer Peter
Schizophrenia: from the brain to peripheral markers. A consensus paper of the WFSBP task force on biological markers.
The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry 2009;10(2):127-55.
2008: Pieper Heike C; Evert Bernd O; Kaut Oliver; Riederer Peter F; Waha Andreas; Wüllner Ullrich
Different methylation of the TNF-alpha promoter in cortex and substantia nigra: Implications for selective neuronal vulnerability.
Neurobiology of disease 2008;32(3):521-7.
2008: Savvateeva-Popova Elena; Popov Andrej; Grossman Abraham; Nikitina Ekaterina; Medvedeva Anna; Molotkov Dmitry; Kamyshev Nicholas; Pyatkov Konstantin; Zatsepina Olga; Schostak Natalya; Zelentsova Elena; Pavlova Galina; Panteleev Dmitry; Riederer Peter; Evgen'ev Michail
Non-coding RNA as a trigger of neuropathologic disorder phenotypes in transgenic Drosophila.
Journal of neural transmission (Vienna, Austria : 1996) 2008;115(12):1629-42.
2008: Schmidt Werner J; Lebsanft Heike; Heindl Manfred; Gerlach Manfred; Gruenblatt Edna; Riederer Peter; Mayerhofer Andreas; Scheller Dieter K A
Continuous versus pulsatile administration of rotigotine in 6-OHDA-lesioned rats: contralateral rotations and abnormal involuntary movements.
Journal of neural transmission (Vienna, Austria : 1996) 2008;115(10):1385-92.
2008: Popov A V; Peresleni A I; Savvateeva-Popova E V; Riederer P
[Effect of mutation-induced excess brain concentration of intermediates of the kynurenine pathway of tryptophan metabolism on stress resistance and courtship behavior and communicative sound production in male Drosophila melanogaster]
Genetika 2008;44(9):1216-26.
2008: Biskup Saskia; Gerlach Manfred; Kupsch Andreas; Reichmann Heinz; Riederer Peter; Vieregge Peter; Wüllner Ullrich; Gasser Thomas
Genes associated with Parkinson syndrome.
Journal of neurology 2008;255 Suppl 5():8-17.
2008: Palm Florian; Mössner Rainald; Chen Yong; He Lan; Gerlach Manfred; Bischofs Stefan; Riederer Peter; Lesch Klaus-Peter; Sommer Claudia
Reduced thermal hyperalgesia and enhanced peripheral nerve injury after hind paw inflammation in mice lacking the serotonin-transporter.
European journal of pain (London, England) 2008;12(6):790-7.
2008: Meisner Falko; Scheller Carsten; Kneitz Susanne; Sopper Sieghart; Neuen-Jacob Eva; Riederer Peter; ter Meulen Volker; Koutsilieri Eleni;
Memantine upregulates BDNF and prevents dopamine deficits in SIV-infected macaques: a novel pharmacological action of memantine.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2008;33(9):2228-36.
2008: Fric M; Pfuhlmann B; Laux G; Riederer P; Distler G; Artmann S; Wohlschläger M; Liebmann M; Deckert J
The influence of smoking on the serum level of duloxetine.
Pharmacopsychiatry 2008;41(4):151-5.
2008: Bell Jeanne E; Alafuzoff Irina; Al-Sarraj Safa; Arzberger Thomas; Bogdanovic Nenad; Budka Herbert; Dexter David T; Falkai Peter; Ferrer Isidro; Gelpi Elena; Gentleman Steven M; Giaccone Giorgio; Huitinga Inge; Ironside James W; Klioueva Natasja; Kovacs Gabor G; Meyronet David; Palkovits Miklos; Parchi Piero; Patsouris Efstatios; Reynolds Richard; Riederer Peter; Roggendorf Wolfgang; Seilhean Danielle; Schmitt Andrea; Schmitz Peer; Streichenberger Nathalie; Schwalber Ameli; Kretzschmar Hans
Management of a twenty-first century brain bank: experience in the BrainNet Europe consortium.
Acta neuropathologica 2008;115(5):497-507.
2008: Sapcanin A; Sofic E; Tahirovic I; Salkovic-Petrisic M; Hoyer S; Riederer P
Antioxidant capacity in rat brain after intracerebroventricular treatment with streptozotocin and alloxan--a preliminary study.
Neurotoxicity research 2008;13(2):97-104.
2008: Riedel Oliver; Klotsche Jens; Spottke Annika; Deuschl Günther; Förstl Hans; Henn Fritz; Heuser Isabella; Oertel Wolfgang; Reichmann Heinz; Riederer Peter; Trenkwalder Claudia; Dodel Richard; Wittchen Hans-Ulrich
Cognitive impairment in 873 patients with idiopathic Parkinson's disease. Results from the German Study on Epidemiology of Parkinson's Disease with Dementia (GEPAD).
Journal of neurology 2008;255(2):255-64.
2008: Meisner Falko; Neuen-Jacob Eva; Sopper Sieghart; Schmidt Michaela; Schlammes Serge; Scheller Carsten; Vosswinkel Daniel; Ter Meulen Volker; Riederer Peter; Koutsilieri Eleni
Disruption of excitatory amino acid transporters in brains of SIV-infected rhesus macaques is associated with microglia activation.
Journal of neurochemistry 2008;104(1):202-9.
2008: Gerlach Manfred; Riederer Peter; Double Kay L
Neuromelanin-bound ferric iron as an experimental model of dopaminergic neurodegeneration in Parkinson's disease.
Parkinsonism & related disorders 2008;14 Suppl 2():S185-8.
2008: Riederer P; Youdim M B H; Mandel S; Gerlach M; Grünblatt E
Genomic aspects of sporadic Parkinson's disease.
Parkinsonism & related disorders 2008;14 Suppl 2():S88-91.
2008: Gerlach Manfred; Hendrich Albrecht; Hueber Roland; Jost Wolfgang; Winkler Jürgen; Woitalla Dirk; Riederer Peter
Early detection of Parkinson's disease: unmet needs.
Neuro-degenerative diseases 2008;5(3-4):137-9.
2007: Grünblatt Edna; Zander Nicole; Bartl Jasmin; Jie Li; Monoranu Camelia-Maria; Arzberger Thomas; Ravid Rivka; Roggendorf Wolfgang; Gerlach Manfred; Riederer Peter
Comparison analysis of gene expression patterns between sporadic Alzheimer's and Parkinson's disease.
Journal of Alzheimer's disease : JAD 2007;12(4):291-311.
2007: Riederer Peter; Gerlach Manfred; Müller Thomas; Reichmann Heinz
Relating mode of action to clinical practice: dopaminergic agents in Parkinson's disease.
Parkinsonism & related disorders 2007;13(8):466-79.
2007: Tahirovic Ismet; Sofic Emin; Sapcanin Aida; Gavrankapetanovic Ismet; Bach-Rojecky Lidija; Salkovic-Petrisic Melita; Lackovic Zdravko; Hoyer Siegfried; Riederer Peter
Reduced brain antioxidant capacity in rat models of betacytotoxic-induced experimental sporadic Alzheimer's disease and diabetes mellitus.
Neurochemical research 2007;32(10):1709-17.
2007: Marziniak M; Mössner R; Kienzler C; Riederer P; Lesch K-P; Sommer C
Functional polymorphisms of the 5-HT1A and 5-HT1B receptor are associated with clinical symptoms in migraineurs.
Journal of neural transmission (Vienna, Austria : 1996) 2007;114(9):1227-32.
2007: Yun Seong-Wook; Ertmer Alexa; Flechsig Eckhard; Gilch Sabine; Riederer Peter; Gerlach Manfred; Schätzl Hermann M; Klein Michael A
The tyrosine kinase inhibitor imatinib mesylate delays prion neuroinvasion by inhibiting prion propagation in the periphery.
Journal of neurovirology 2007;13(4):328-37.
2007: Yun Seong-Wook; Kouznetsova Elena; Nitschke Cindy; Heinitz Katrin; Schliebs Reinhard; Gerlach Manfred; Riederer Peter; Klein Michael A
beta-Amyloid deposition and prion infection in adult primary brain cell long-term culture model.
Biochemical and biophysical research communications 2007;360(3):520-4.
2007: Arendt Gabriele; Nolting Thorsten; Frisch Christian; Husstedt Ingo-Wilhelm; Gregor Nora; Koutsilieri Eleni; Maschke Mattias; Angerer Alexander; Obermann Mark; Neuen-Jacob Eva; Adams Ortwin; Loeffert Sabine; Riederer Peter; ter Meulen Volker; Sopper Sieghart;
Intrathecal viral replication and cerebral deficits in different stages of human immunodeficiency virus disease.
Journal of neurovirology 2007;13(3):225-32.
2007: Ulrich S; Hiemke C; Laux G; Müller-Oerlinghausen B; Havemann-Reinecke U; Riederer P; Zernig G; Baumann P;
Value and actuality of the prescription information for therapeutic drug monitoring of psychopharmaceuticals: a comparison with the medico-scientific evidence.
Pharmacopsychiatry 2007;40(3):121-7.
2007: Grünblatt Edna; Salkovic-Petrisic Melita; Osmanovic Jelena; Riederer Peter; Hoyer Siegfried
Brain insulin system dysfunction in streptozotocin intracerebroventricularly treated rats generates hyperphosphorylated tau protein.
Journal of neurochemistry 2007;101(3):757-70.
2007: Michel Tanja Maria; Frangou Sophia; Thiemeyer Dorothea; Camara Sibylle; Jecel Julia; Nara Keinosuke; Brunklaus Andreas; Zoechling Robert; Riederer Peter
Evidence for oxidative stress in the frontal cortex in patients with recurrent depressive disorder--a postmortem study.
Psychiatry research 2007;151(1-2):145-50.
2007: Plochmann Kathrin; Korte Gabriele; Koutsilieri Eleni; Richling Elke; Riederer Peter; Rethwilm Axel; Schreier Peter; Scheller Carsten
Structure-activity relationships of flavonoid-induced cytotoxicity on human leukemia cells.
Archives of biochemistry and biophysics 2007;460(1):1-9.
2007: Hoyer Siegfried; Riederer Peter
Alzheimer disease--no target for statin treatment. A mini review.
Neurochemical research 2007;32(4-5):695-706.
2007: Jacob C P; Koutsilieri E; Bartl J; Neuen-Jacob E; Arzberger T; Zander N; Ravid R; Roggendorf W; Riederer P; Grünblatt E
Alterations in expression of glutamatergic transporters and receptors in sporadic Alzheimer's disease.
Journal of Alzheimer's disease : JAD 2007;11(1):97-116.
2007: Mössner Rainald; Riederer Peter
Allelic variation of a functional promoter polymorphism of the serotonin transporter and depression in Parkinson's disease.
Parkinsonism & related disorders 2007;13(1):62.
2007: Youdim Moussa B H; Riederer Peter F
Monoamine oxidase A and B inhibitors in Parkinson's disease.
Handbook of clinical neurology / edited by P.J. Vinken and G.W. Bruyn 2007;84():93-120.
2007: Koutsilieri Eleni; Riederer Peter
Excitotoxicity and new antiglutamatergic strategies in Parkinson's disease and Alzheimer's disease.
Parkinsonism & related disorders 2007;13 Suppl 3():S329-31.
2007: Kneitz S; Meisner F; Sopper S; Kaiser F; Grünblatt E; Scheller C; Riederer P; ter Meulen V; Koutsilieri E
Biostatistical analysis of gene microarrays reveals diverse expression clusters between macaque subspecies in brain SIV infection.
Journal of neural transmission. Supplementum 2007;(72):317-22.
2007: Pfuhlmann B; Gerlach M; Burger R; Gonska S; Unterecker S; Jabs B; Riederer P; Deckert J
Therapeutic drug monitoring of tricyclic antidepressants in everyday clinical practice.
Journal of neural transmission. Supplementum 2007;(72):287-96.
2007: Tahirovic I; Sofic E; Sapcanin A; Gavrankapetanovic I; Bach-Rojecky L; Salkovic-Petrisic M; Lackovic Z; Hoyer S; Riederer P
Brain antioxidant capacity in rat models of betacytotoxic-induced experimental sporadic Alzheimer's disease and diabetes mellitus.
Journal of neural transmission. Supplementum 2007;(72):235-40.
2007: Fischer P; Krampla W; Mostafaie N; Zehetmayer S; Rainer M; Jungwirth S; Huber K; Bauer K; Hruby W; Riederer P; Tragl K H
VITA study: white matter hyperintensities of vascular and degenerative origin in the elderly.
Journal of neural transmission. Supplementum 2007;(72):181-8.
2007: Tribl F; Arzberger T; Riederer P; Gerlach M
Tyrosinase is not detected in human catecholaminergic neurons by immunohistochemistry and Western blot analysis.
Journal of neural transmission. Supplementum 2007;(72):51-5.
2007: Moser Dirk; Molitor Anne; Kumsta Robert; Tatschner Thomas; Riederer Peter; Meyer Jobst
The glucocorticoid receptor gene exon 1-F promoter is not methylated at the NGFI-A binding site in human hippocampus.
The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry 2007;8(4):262-8.
2007: Shamoto-Nagai M; Maruyama W; Hashizume Y; Yoshida M; Osawa T; Riederer P; Naoi M
In parkinsonian substantia nigra, alpha-synuclein is modified by acrolein, a lipid-peroxidation product, and accumulates in the dopamine neurons with inhibition of proteasome activity.
Journal of neural transmission (Vienna, Austria : 1996) 2007;114(12):1559-67.
2007: Mössner Rainald; Mikova Olya; Koutsilieri Eleni; Saoud Mohamed; Ehlis Ann-Christince; Müller Norbert; Fallgatter Andreas J; Riederer Peter
Consensus paper of the WFSBP Task Force on Biological Markers: biological markers in depression.
The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry 2007;8(3):141-74.
2007: Depboylu Candan; Matusch Andreas; Tribl Florian; Zoriy Myroslav; Michel Patrick P; Riederer Peter; Gerlach Manfred; Becker Sabine; Oertel Wolfgang H; Höglinger Günter U
Glia protects neurons against extracellular human neuromelanin.
Neuro-degenerative diseases 2007;4(2-3):218-26.
2007: Schmitt A; Bauer M; Heinsen H; Feiden W; Falkai P; Alafuzoff I; Arzberger T; Al-Sarraj S; Bell J E; Bogdanovic N; Brück W; Budka H; Ferrer I; Giaccone G; Kovacs G G; Meyronet D; Palkovits M; Parchi P; Patsouris E; Ravid R; Reynolds R; Riederer P; Roggendorf W; Schwalber A; Seilhean D; Kretzschmar H
How a neuropsychiatric brain bank should be run: a consensus paper of Brainnet Europe II.
Journal of neural transmission (Vienna, Austria : 1996) 2007;114(5):527-37.
2006: Mehler-Wex C; Riederer P; Gerlach M
Dopaminergic dysbalance in distinct basal ganglia neurocircuits: implications for the pathophysiology of Parkinson's disease, schizophrenia and attention deficit hyperactivity disorder.
Neurotoxicity research 2006;10(3-4):167-79.
2006: Riederer P; Hoyer S
From benefit to damage. Glutamate and advanced glycation end products in Alzheimer brain.
Journal of neural transmission (Vienna, Austria : 1996) 2006;113(11):1671-7.
2006: Grünblatt E; Hupp E; Bambula M; Zehetmayer S; Jungwirth S; Tragl K H; Fischer P; Riederer P
Association study of BDNF and CNTF polymorphism to depression in non-demented subjects of the "VITA" study.
Journal of affective disorders 2006;96(1-2):111-6.
2006: Luckhaus Christian; Spiegler Christian; Ibach Bernd; Fischer Peter; Wichart Ildiko; Sterba Nadine; Gatterer Gerald; Rainer Michael; Jungwirth Susanne; Huber Klaus; Tragl Karl H; Grünblatt Edna; Riederer Peter; Sand Philipp G
Estrogen receptor beta gene (ESRbeta) 3'-UTR variants in Alzheimer disease.
Alzheimer disease and associated disorders 2006;20(4):322-3.
2006: Kornhuber Johannes; Riederer Peter; Bleich Stefan; Wiltfang Jens; Kraus Thomas; Meineke Ingolf
Pharmacokinetic characterization of amantadine in human brain tissue.
Therapeutic drug monitoring 2006;28(5):693-5.
2006: Mössner Rainald; Yun Seong-Wook; Lesch Klaus-Peter; Gerlach Manfred; Klein Michael A; Riederer Peter
Unaltered susceptibility to scrapie in serotonin transporter deficient mice.
Neurochemistry international 2006;49(5):454-8.
2006: Grünblatt Edna; Löffler Christiane; Zehetmayer Sonja; Jungwirth Susanne; Tragl Karl-Heinz; Riederer Peter; Fischer Peter
Association study of the 5-HTTLPR polymorphism and depression in 75-Year-Old nondemented subjects from the Vienna Transdanube Aging (VITA) study.
The Journal of clinical psychiatry 2006;67(9):1373-8.
2006: Hamacher Michael; Apweiler Rolf; Arnold Georg; Becker Albert; Blüggel Martin; Carrette Odile; Colvis Christine; Dunn Michael J; Fröhlich Thomas; Fountoulakis Michael; van Hall André; Herberg Friedrich; Ji Jianguo; Kretzschmar Hans; Lewczuk Piotr; Lubec Gert; Marcus Katrin; Martens Lennart; Palacios Bustamante Nadine; Park Young Mok; Pennington Stephen R; Robben Johan; Stühler Kai; Reidegeld Kai A; Riederer Peter; Rossier Jean; Sanchez Jean-Charles; Schrader Michael; Stephan Christian; Tagle Danilo; Thiele Herbert; Wang Jing; Wiltfang Jens; Yoo Jong Shin; Zhang Chenggang; Klose Joachim; Meyer Helmut E
HUPO Brain Proteome Project: summary of the pilot phase and introduction of a comprehensive data reprocessing strategy.
Proteomics 2006;6(18):4890-8.
2006: Yun Seong-Wook; Gerlach Manfred; Riederer Peter; Klein Michael A
Oxidative stress in the brain at early preclinical stages of mouse scrapie.
Experimental neurology 2006;201(1):90-8.
2006: Grünblatt Edna; Koutsilieri Eleni; Hoyer Siegfried; Riederer Peter
Gene expression alterations in brain areas of intracerebroventricular streptozotocin treated rat.
Journal of Alzheimer's disease : JAD 2006;9(3):261-71.
2006: Tribl F; Marcus K; Bringmann G; Meyer H E; Gerlach M; Riederer P
Proteomics of the human brain: sub-proteomes might hold the key to handle brain complexity.
Journal of neural transmission (Vienna, Austria : 1996) 2006;113(8):1041-54.
2006: Kornhuber Johannes; Wiltfang Jens; Riederer Peter; Bleich Stefan
Neuroleptic drugs in the human brain: clinical impact of persistence and region-specific distribution.
European archives of psychiatry and clinical neuroscience 2006;256(5):274-80.
2006: Tribl F; Marcus K; Meyer H E; Bringmann G; Gerlach M; Riederer P
Subcellular proteomics reveals neuromelanin granules to be a lysosome-related organelle.
Journal of neural transmission (Vienna, Austria : 1996) 2006;113(6):741-9.
2006: Fedorow H; Pickford R; Kettle E; Cartwright M; Halliday G M; Gerlach M; Riederer P; Garner B; Double K L
Investigation of the lipid component of neuromelanin.
Journal of neural transmission (Vienna, Austria : 1996) 2006;113(6):735-9.
2006: Dzierzega-Lecznar A; Kurkiewicz S; Stepien K; Chodurek E; Riederer P; Gerlach M
Structural investigations of neuromelanin by pyrolysis-gas chromatography/mass spectrometry.
Journal of neural transmission (Vienna, Austria : 1996) 2006;113(6):729-34.
2006: Halliday G M; Fedorow H; Rickert C H; Gerlach M; Riederer P; Double K L
Evidence for specific phases in the development of human neuromelanin.
Journal of neural transmission (Vienna, Austria : 1996) 2006;113(6):721-8.
2006: Völkel Wolfgang; Sicilia Tina; Pähler Axel; Gsell W; Tatschner Thomas; Jellinger Kurt; Leblhuber Friedrich; Riederer Peter; Lutz Werner K; Götz Mario E
Increased brain levels of 4-hydroxy-2-nonenal glutathione conjugates in severe Alzheimer's disease.
Neurochemistry international 2006;48(8):679-86.
2006: Baumann P; Hiemke C; Ulrich S; Eckermann G; Kuss H L; Laux G; Müller-Oerlingenhausen B; Rao M L; Riederer P; Zernig G;
[Therapeutic drug monitoring (TDM) of psychotropic drugs: a consensus guideline of the AGNP-TDM group]
Revue médicale suisse 2006;2(67):1413-8, 1420-2, 1424-6.
2006: Shamoto-Nagai M; Maruyama W; Yi H; Akao Y; Tribl F; Gerlach M; Osawa T; Riederer P; Naoi M
Neuromelanin induces oxidative stress in mitochondria through release of iron: mechanism behind the inhibition of 26S proteasome.
Journal of neural transmission (Vienna, Austria : 1996) 2006;113(5):633-44.
2006: Kornhuber J; Weigmann H; Röhrich J; Wiltfang J; Bleich S; Meineke I; Zöchling R; Härtter S; Riederer P; Hiemke C
Region specific distribution of levomepromazine in the human brain.
Journal of neural transmission (Vienna, Austria : 1996) 2006;113(3):387-97.
2006: Fedorow H; Halliday G M; Rickert C H; Gerlach M; Riederer P; Double K L
Evidence for specific phases in the development of human neuromelanin.
Neurobiology of aging 2006;27(3):506-12.
2006: Salkovic-Petrisic Melita; Tribl Florian; Schmidt Manuela; Hoyer Siegfried; Riederer Peter
Alzheimer-like changes in protein kinase B and glycogen synthase kinase-3 in rat frontal cortex and hippocampus after damage to the insulin signalling pathway.
Journal of neurochemistry 2006;96(4):1005-15.
2006: Glatz Daniela C; Rujescu Dan; Tang Yesheng; Berendt Frank J; Hartmann Annette M; Faltraco Frank; Rosenberg Carlyn; Hulette Christine; Jellinger Kurt; Hampel Harald; Riederer Peter; Möller Hans-J; Andreadis Athena; Henkel Kerstin; Stamm Stefan
The alternative splicing of tau exon 10 and its regulatory proteins CLK2 and TRA2-BETA1 changes in sporadic Alzheimer's disease.
Journal of neurochemistry 2006;96(3):635-44.
2006: Scheller C; Riederer P; Gerlach M; Koutsilieri E
Apoptosis inhibition in T cells triggers the expression of proinflammatory cytokines--implications for the CNS.
Journal of neural transmission. Supplementum 2006;(71):45-51.
2006: Sofic E; Sapcanin A; Tahirovic I; Gavrankapetanovic I; Jellinger K; Reynolds G P; Tatschner T; Riederer P
Antioxidant capacity in postmortem brain tissues of Parkinson's and Alzheimer's diseases.
Journal of neural transmission. Supplementum 2006;(71):39-43.
2006: Gerlach M; Double K L; Youdim M B H; Riederer P
Potential sources of increased iron in the substantia nigra of parkinsonian patients.
Journal of neural transmission. Supplementum 2006;(70):133-42.
2006: Maruyama W; Shamoto-Nagai M; Akao Y; Riederer P; Naoi M
The effect of neuromelanin on the proteasome activity in human dopaminergic SH-SY5Y cells.
Journal of neural transmission. Supplementum 2006;(70):125-32.
2005: Scheller Carsten; Sopper Sieghart; Jenuwein Meta; Neuen-Jacob Eva; Tatschner Thomas; Grünblatt Edna; ter Meulen Volker; Riederer Peter; Koutsilieri Eleni
Early impairment in dopaminergic neurotransmission in brains of SIV-infected rhesus monkeys due to microglia activation.
Journal of neurochemistry 2005;95(2):377-87.
2005: Salkovic-Petrisic M; Lackovic Z; Hoyer S; Riederer P
Central administration of alloxan impairs glucose tolerance in rats.
Journal of neural transmission (Vienna, Austria : 1996) 2005;112(10):1391-5.
2005: Li Jie; Scheller Carsten; Koutsilieri Eleni; Griffiths Francine; Beart Philip M; Mercer Linda D; Halliday Glenda; Kettle Emma; Rowe Dominic; Riederer Peter; Gerlach Manfred; Rodriguez Michael; Double Kay L
Differential effects of human neuromelanin and synthetic dopamine melanin on neuronal and glial cells.
Journal of neurochemistry 2005;95(2):599-608.
2005: Zecca Luigi; Berg Daniela; Arzberger Thomas; Ruprecht Petra; Rausch Wolf D; Musicco Massimo; Tampellini Davide; Riederer Peter; Gerlach Manfred; Becker Georg
In vivo detection of iron and neuromelanin by transcranial sonography: a new approach for early detection of substantia nigra damage.
Movement disorders : official journal of the Movement Disorder Society 2005;20(10):1278-85.
2005: Götz M E; Malz C R; Dirr A; Blum D; Gsell W; Schmidt S; Burger R; Pohli S; Riederer P
Brain aging phenomena in migrating sockeye salmon Oncorhynchus nerka nerka.
Journal of neural transmission (Vienna, Austria : 1996) 2005;112(9):1177-99.
2005: Mandel Silvia; Grunblatt Edna; Riederer Peter; Amariglio Ninette; Jacob-Hirsch Jasmine; Rechavi Gideon; Youdim Moussa B H
Gene expression profiling of sporadic Parkinson's disease substantia nigra pars compacta reveals impairment of ubiquitin-proteasome subunits, SKP1A, aldehyde dehydrogenase, and chaperone HSC-70.
Annals of the New York Academy of Sciences 2005;1053():356-75.
2005: Tribl Florian; Gerlach Manfred; Marcus Katrin; Asan Esther; Tatschner Thomas; Arzberger Thomas; Meyer Helmut E; Bringmann Gerhard; Riederer Peter
"Subcellular proteomics" of neuromelanin granules isolated from the human brain.
Molecular & cellular proteomics : MCP 2005;4(7):945-57.
2005: Gerlach Manfred; Reichmann Heinz; Riederer Peter
Levodopa in the treatment of Parkinson's disease: current controversies.
Movement disorders : official journal of the Movement Disorder Society 2005;20(5):643; author reply 643-4.
2005: Graf M; Ecker D; Horowski R; Kramer B; Riederer P; Gerlach M; Hager C; Ludolph A C; Becker G; Osterhage J; Jost W H; Schrank B; Stein C; Kostopulos P; Lubik S; Wekwerth K; Dengler R; Troeger M; Wuerz A; Hoge A; Schrader C; Schimke N; Krampfl K; Petri S; Zierz S; Eger K; Neudecker S; Traufeller K; Sievert M; Neundörfer B; Hecht M;
High dose vitamin E therapy in amyotrophic lateral sclerosis as add-on therapy to riluzole: results of a placebo-controlled double-blind study.
Journal of neural transmission (Vienna, Austria : 1996) 2005;112(5):649-60.
2005: Grünblatt E; Schlösser R; Fischer P; Fischer M O; Li J; Koutsilieri E; Wichart I; Sterba N; Rujescu D; Möller H J; Adamcyk W; Dittrich B; Müller F; Oberegger K; Gatterer G; Jellinger K J; Mostafaie N; Jungwirth S; Huber K; Tragl K H; Danielczyk W; Riederer P
Oxidative stress related markers in the "VITA" and the centenarian projects.
Neurobiology of aging 2005;26(4):429-38.
2005: Fedorow H; Tribl F; Halliday G; Gerlach M; Riederer P; Double K L
Neuromelanin in human dopamine neurons: comparison with peripheral melanins and relevance to Parkinson's disease.
Progress in neurobiology 2005;75(2):109-24.
2005: Fedorow Heidi; Pickford Russell; Hook James M; Double Kay L; Halliday Glenda M; Gerlach Manfred; Riederer Peter; Garner Brett
Dolichol is the major lipid component of human substantia nigra neuromelanin.
Journal of neurochemistry 2005;92(4):990-5.
2005: Wiltfang J; Lewczuk P; Riederer P; Grünblatt E; Hock C; Scheltens P; Hampel H; Vanderstichele H; Iqbal K; Galasko D; Lannfelt L; Otto M; Esselmann H; Henkel A W; Kornhuber J; Blennow K
Consensus paper of the WFSBP Task Force on Biological Markers of Dementia: the role of CSF and blood analysis in the early and differential diagnosis of dementia.
The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry 2005;6(2):69-84.
2005: Baumann Pierre; Ulrich Sven; Eckermann Gabriel; Gerlach Manfred; Kuss Hans-Joachim; Laux Gerd; Müller-Oerlinghausen Bruno; Rao Marie Luise; Riederer Peter; Zernig Gerald; Hiemke Christoph;
The AGNP-TDM Expert Group Consensus Guidelines: focus on therapeutic monitoring of antidepressants.
Dialogues in clinical neuroscience 2005;7(3):231-47.
2005: Lauer Martin; Johannes Silvia; Fritzen Sabrina; Senitz Dieter; Riederer Peter; Reif Andreas
Morphological abnormalities in nitric-oxide-synthase-positive striatal interneurons of schizophrenic patients.
Neuropsychobiology 2005;52(3):111-7.
2004: Grünblatt E; Mandel S; Jacob-Hirsch J; Zeligson S; Amariglo N; Rechavi G; Li J; Ravid R; Roggendorf W; Riederer P; Youdim M B H
Gene expression profiling of parkinsonian substantia nigra pars compacta; alterations in ubiquitin-proteasome, heat shock protein, iron and oxidative stress regulated proteins, cell adhesion/cellular matrix and vesicle trafficking genes.
Journal of neural transmission (Vienna, Austria : 1996) 2004;111(12):1543-73.
2004: Baumann P; Hiemke C; Ulrich S; Eckermann G; Gaertner I; Gerlach M; Kuss H-J; Laux G; Müller-Oerlinghausen B; Rao M L; Riederer P; Zernig G;
The AGNP-TDM expert group consensus guidelines: therapeutic drug monitoring in psychiatry.
Pharmacopsychiatry 2004;37(6):243-65.
2004: Gerlach Manfred; van den Buuse Maarten; Blaha Charles; Bremen Dirk; Riederer Peter
Entacapone increases and prolongs the central effects of l-DOPA in the 6-hydroxydopamine-lesioned rat.
Naunyn-Schmiedeberg's archives of pharmacology 2004;370(5):388-94.
2004: Zecca Luigi; Youdim Moussa B H; Riederer Peter; Connor James R; Crichton Robert R
Iron, brain ageing and neurodegenerative disorders.
Nature reviews. Neuroscience 2004;5(11):863-73.
2004: Foley P; Gerlach M; Double K L; Riederer P
Dopamine receptor agonists in the therapy of Parkinson's disease.
Journal of neural transmission (Vienna, Austria : 1996) 2004;111(10-11):1375-446.
2004: Shamoto-Nagai M; Maruyama W; Akao Y; Osawa T; Tribl F; Gerlach M; Zucca F A; Zecca L; Riederer P; Naoi M
Neuromelanin inhibits enzymatic activity of 26S proteasome in human dopaminergic SH-SY5Y cells.
Journal of neural transmission (Vienna, Austria : 1996) 2004;111(10-11):1253-65.
2004: Riederer P F; Hirsch E; Youdim M B H; Calne D B
A tribute for Prof. Dr. Melvin D. Yahr, M.D. (1917-2004).
Journal of neural transmission (Vienna, Austria : 1996) 2004;111(10-11):1205-8.
2004: Youdim Moussa B H; Riederer Peter F
A review of the mechanisms and role of monoamine oxidase inhibitors in Parkinson's disease.
Neurology 2004;63(7 Suppl 2):S32-5.
2004: Berg Daniela; Youdim Moussa B H; Riederer Peter
Redox imbalance.
Cell and tissue research 2004;318(1):201-13.
2004: Renner André; Sagstetter Martina R; Götz Mario E; Lange Volkmar; Bengel Dominik; Harms Harry; Riederer Peter; Elert Olaf
Heterotopic rat heart transplantation: severe loss of glutathione in 8-hour ischemic hearts.
The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation 2004;23(9):1093-102.
2004: Riederer P; Lachenmayer L; Laux G
Clinical applications of MAO-inhibitors.
Current medicinal chemistry 2004;11(15):2033-43.
2004: Morawski Markus; Brückner Martina K; Riederer Peter; Brückner Gert; Arendt Thomas
Perineuronal nets potentially protect against oxidative stress.
Experimental neurology 2004;188(2):309-15.
2004: Kavvadias Dominique; Sand Philipp; Youdim Kuresh A; Qaiser M Zeeshan; Rice-Evans Catherine; Baur Roland; Sigel Erwin; Rausch Wolf-Dieter; Riederer Peter; Schreier Peter
The flavone hispidulin, a benzodiazepine receptor ligand with positive allosteric properties, traverses the blood-brain barrier and exhibits anticonvulsive effects.
British journal of pharmacology 2004;142(5):811-20.
2004: Jenuwein M; Scheller C; Neuen-Jacob E; Sopper S; Tatschner T; ter Meulen V; Riederer P; Koutsilieri E
Dopamine deficits and regulation of the cAMP second messenger system in brains of simian immunodeficiency virus-infected rhesus monkeys.
Journal of neurovirology 2004;10(3):163-70.
2004: Heim C; Sontag T A; Kolasiewicz W; Ulrich F; Pardowitz I; Horn H J; Gerlach M; Riederer P; Sontag K-H
Consequences of a single short lasting cerebral oligemia and the influence of iron injected into the substantia nigra or in the ventrolateral striatum of the rat. Trigger of Parkinson's disease pathogenesis?
Journal of neural transmission (Vienna, Austria : 1996) 2004;111(6):641-66.
2004: Dzierzega-Lecznar Anna; Kurkiewicz Slawomir; Stepien Krystyna; Chodurek Ewa; Wilczok Tadeusz; Arzberger Thomas; Riederer Peter; Gerlach Manfred
GC/MS analysis of thermally degraded neuromelanin from the human substantia nigra.
Journal of the American Society for Mass Spectrometry 2004;15(6):920-6.
2004: Baumann P; Hiemke C; Ulrich S; Gaertner I; Rao M L; Eckermann G; Gerlach M; Kuss H J; Laux G; Müller-Oerlinghausen B; Riederer P; Zernig G
Therapeutic monitoring of psychotropic drugs: an outline of the AGNP-TDM expert group consensus guideline.
Therapeutic drug monitoring 2004;26(2):167-70.
2004: Götz Mario E; Double Kay; Gerlach Manfred; Youdim Moussa B H; Riederer Peter
The relevance of iron in the pathogenesis of Parkinson's disease.
Annals of the New York Academy of Sciences 2004;1012():193-208.
2004: Grünblatt E; Hoyer S; Riederer P
Gene expression profile in streptozotocin rat model for sporadic Alzheimer's disease.
Journal of neural transmission (Vienna, Austria : 1996) 2004;111(3):367-86.
2004: Hashimoto E; Ozawa H; Saito T; Gsell W; Takahata N; Riederer P; Frölich L
Impairment of G(salpha) function in human brain cortex of Alzheimer's disease: comparison with normal aging.
Journal of neural transmission (Vienna, Austria : 1996) 2004;111(3):311-22.
2004: Frölich L; Götz M E; Weinmüller M; Youdim M B H; Barth N; Dirr A; Gsell W; Jellinger K; Beckmann H; Riederer P
(r)-, but not (s)-alpha lipoic acid stimulates deficient brain pyruvate dehydrogenase complex in vascular dementia, but not in Alzheimer dementia.
Journal of neural transmission (Vienna, Austria : 1996) 2004;111(3):295-310.
2004: Czub S; Czub M; Koutsilieri E; Sopper S; Villinger F; Müller J G; Stahl-Hennig C; Riederer P; Ter Meulen V; Gosztonyi G
Modulation of simian immunodeficiency virus neuropathology by dopaminergic drugs.
Acta neuropathologica 2004;107(3):216-26.
2004: Przuntek H; Müller Th; Riederer P
Diagnostic staging of Parkinson's disease: conceptual aspects.
Journal of neural transmission (Vienna, Austria : 1996) 2004;111(2):201-16.
2004: Mössner R; Schmitt A; Hennig T; Benninghoff J; Gerlach M; Riederer P; Deckert J; Lesch K P
Quantitation of 5HT3 receptors in forebrain of serotonin transporter deficient mice.
Journal of neural transmission (Vienna, Austria : 1996) 2004;111(1):27-35.
2004: Riederer Peter; Danielczyk Walter; Grünblatt Edna
Monoamine oxidase-B inhibition in Alzheimer's disease.
Neurotoxicology 2004;25(1-2):271-7.
2004: Koutsilieri E; Scheller C; ter Meulen V; Riederer P
Monoamine oxidase inhibition and CNS immunodeficiency infection.
Neurotoxicology 2004;25(1-2):267-70.
2004: Braungart Evelyn; Gerlach Manfred; Riederer Peter; Baumeister Ralf; Hoener Marius C
Caenorhabditis elegans MPP+ model of Parkinson's disease for high-throughput drug screenings.
Neuro-degenerative diseases 2004;1(4-5):175-83.
2004: Götz Mario E; Riederer Peter
Advances in neuroprotection research for neurodegenerative diseases.
Advances in experimental medicine and biology 2004;541():1-19.
2004: Gsell Wieland; Jungkunz Gerd; Riederer Peter
Functional neurochemistry of Alzheimer's disease.
Current pharmaceutical design 2004;10(3):265-93.
2003: Fallgatter A J; Neuhauser B; Herrmann M J; Ehlis A-C; Wagener A; Scheuerpflug P; Reiners K; Riederer P
Far field potentials from the brain stem after transcutaneous vagus nerve stimulation.
Journal of neural transmission (Vienna, Austria : 1996) 2003;110(12):1437-43.
2003: Double K L; Halliday G M; Henderson J; Griffiths F M; Heinemann T; Riederer P; Gerlach M
The dopamine receptor agonist lisuride attenuates iron-mediated dopaminergic neurodegeneration.
Experimental neurology 2003;184(1):530-5.
2003: Riederer P; Lachenmayer L
Selegiline's neuroprotective capacity revisited.
Journal of neural transmission (Vienna, Austria : 1996) 2003;110(11):1273-8.
2003: Gerlach M; Double K; Arzberger T; Leblhuber F; Tatschner T; Riederer P
Dopamine receptor agonists in current clinical use: comparative dopamine receptor binding profiles defined in the human striatum.
Journal of neural transmission (Vienna, Austria : 1996) 2003;110(10):1119-27.
2003: Double Kay L; Gerlach Manfred; Schünemann Volker; Trautwein Alfred X; Zecca Luigi; Gallorini Mario; Youdim Moussa B H; Riederer Peter; Ben-Shachar Dorit
Iron-binding characteristics of neuromelanin of the human substantia nigra.
Biochemical pharmacology 2003;66(3):489-94.
2003: Johannes Silvia; Reif Andreas; Senitz Dieter; Riederer Peter; Lauer Martin
NADPH-diaphorase staining reveals new types of interneurons in human putamen.
Brain research 2003;980(1):92-9.
2003: Hoyer S; Riederer P
[Pathomechanisms and hypothesis-guided therapeutic strategies for late-onset Alzheimer's disease]
Fortschritte der Neurologie-Psychiatrie 2003;71 Suppl 1():S16-26.
2003: Yamada S; Yamamoto M; Ozawa H; Riederer P; Saito T
Reduced phosphorylation of cyclic AMP-responsive element binding protein in the postmortem orbitofrontal cortex of patients with major depressive disorder.
Journal of neural transmission (Vienna, Austria : 1996) 2003;110(6):671-80.
2003: Takeuchi Masayoshi; Watai Takayuki; Sasaki Nobuyuki; Choei Hiroshi; Iwaki Mina; Ashizawa Takeshi; Inagaki Yosuke; Yamagishi Sho-Ichi; Kikuchi Seiji; Riederer Peter; Saito Toshikazu; Bucala Richard; Kameda Yukihiko
Neurotoxicity of acetaldehyde-derived advanced glycation end products for cultured cortical neurons.
Journal of neuropathology and experimental neurology 2003;62(5):486-96.
2003: Münch Gerald; Gasic-Milenkovic Jovana; Dukic-Stefanovic Sladjana; Kuhla Björn; Heinrich Katrin; Riederer Peter; Huttunen Henri J; Founds Hank; Sajithlal Gangadharan
Microglial activation induces cell death, inhibits neurite outgrowth and causes neurite retraction of differentiated neuroblastoma cells.
Experimental brain research. Experimentelle Hirnforschung. Expérimentation cérébrale 2003;150(1):1-8.
2003: Deckert Jürgen; Brenner Markus; Durany Nuria; Zöchling Robert; Paulus Werner; Ransmayr Gerhard; Tatschner Thomas; Danielczyk Walter; Jellinger Kurt; Riederer Peter
Up-regulation of striatal adenosine A(2A) receptors in schizophrenia.
Neuroreport 2003;14(3):313-6.
2003: Gerlach M; Riederer P
[Current preclinical findings on substances against Parkinson's disease]
Der Nervenarzt 2003;74 Suppl 1():S2-6.
2003: Gerlach M; Foley P; Riederer P
The relevance of preclinical studies for the treatment of Parkinson's disease.
Journal of neurology 2003;250 Suppl 1():I31-4.
2003: Kavvadias Dominique; Monschein Vanessa; Sand Philipp; Riederer Peter; Schreier Peter
Constituents of sage (Salvia officinalis) with in vitro affinity to human brain benzodiazepine receptor.
Planta medica 2003;69(2):113-7.
2003: Vogel Carola; Mössner Rainald; Gerlach Manfred; Heinemann Thoralf; Murphy Dennis L; Riederer Peter; Lesch Klaus-Peter; Sommer Claudia
Absence of thermal hyperalgesia in serotonin transporter-deficient mice.
The Journal of neuroscience : the official journal of the Society for Neuroscience 2003;23(2):708-15.
2003: Savvateeva-Popova Elena V; Popov Andrey V; Heinemann Thoralf; Riederer Peter
Drosophila mutants of the kynurenine pathway as a model for ageing studies.
Advances in experimental medicine and biology 2003;527():713-22.
2003: Gerlach M; Double K; Reichmann H; Riederer P
Arguments for the use of dopamine receptor agonists in clinical and preclinical Parkinson's disease.
Journal of neural transmission. Supplementum 2003;(65):167-83.
2003: Zecca L; Zucca F A; Costi P; Tampellini D; Gatti A; Gerlach M; Riederer P; Fariello R G; Ito S; Gallorini M; Sulzer D
The neuromelanin of human substantia nigra: structure, synthesis and molecular behaviour.
Journal of neural transmission. Supplementum 2003;(65):145-55.
2003: Mandel Silvia; Grünblatt Edna; Riederer Peter; Gerlach Manfred; Levites Yona; Youdim Moussa B H
Neuroprotective strategies in Parkinson's disease : an update on progress.
CNS drugs 2003;17(10):729-62.
2003: Gerlach Manfred; Double Kay L; Ben-Shachar Dorit; Zecca Luigi; Youdim Moussa B H; Riederer Peter
Neuromelanin and its interaction with iron as a potential risk factor for dopaminergic neurodegeneration underlying Parkinson's disease.
Neurotoxicity research 2003;5(1-2):35-44.
2003: Riederer P
Is there a subtype of developmental Parkinson's disease?
Neurotoxicity research 2003;5(1-2):27-34.
2003: Grünblatt Edna; Schlösser Robert; Gerlach Manfred; Riederer Peter
Preclinical versus clinical neuroprotection.
Advances in neurology 2003;91():309-28.
2003: Mandel Silvia; Grünblatt Edna; Riederer Peter; Youdim Moussa B H
Genes and oxidative stress in parkinsonism: cDNA microarray studies.
Advances in neurology 2003;91():123-32.
2002: Koutsilieri E; Scheller C; Sopper S; ter Meulen V; Riederer P
Psychiatric complications in human immunodeficiency virus infection.
Journal of neurovirology 2002;8 Suppl 2():129-33.
2002: Riederer P; Foley P
Mini-review: multiple developmental forms of parkinsonism. The basis for further research as to the pathogenesis of parkinsonism.
Journal of neural transmission (Vienna, Austria : 1996) 2002;109(12):1469-75.
2002: Sand P G; Mori T; Godau C; Stöber G; Flachenecker P; Franke P; Nöthen M M; Fritze J; Maier W; Lesch K-P; Riederer P; Beckmann H; Deckert J
Norepinephrine transporter gene (NET) variants in patients with panic disorder.
Neuroscience letters 2002;333(1):41-4.
2002: Riederer P; Gille G; Müller T; Przuntek H; Reichmann H; Riess O; Schwartz A; Schwarz J; Vogt T
Practical importance of neuroprotection in Parkinson's disease.
Journal of neurology 2002;249 Suppl 3():III/53-6.
2002: Koutsilieri E; Scheller C; Grünblatt E; Nara K; Li J; Riederer P
Free radicals in Parkinson's disease.
Journal of neurology 2002;249 Suppl 2():II1-5.
2002: Koutsilieri E; Scheller C; Tribl F; Riederer P
Degeneration of neuronal cells due to oxidative stress--microglial contribution.
Parkinsonism & related disorders 2002;8(6):401-6.
2002: Double K L; Ben-Shachar D; Youdim M B H; Zecca L; Riederer P; Gerlach M
Influence of neuromelanin on oxidative pathways within the human substantia nigra.
Neurotoxicology and teratology 2002;24(5):621-8.
2002: Dukic-Stefanovic Sladjana; Schicktanz Dorothee; Wong Amanda; Palm Dieter; Riederer Peter; Niwa Toshimitsu; Schinzel Reinhard; Münch Gerald
Characterization of antibody affinities using an AGE-modified dipeptide spot library.
Journal of immunological methods 2002;266(1-2):45-52.
2002: Meyer J; Saam W; Mössner R; Cangir O; Ortega G R; Tatschner T; Riederer P; Wienker T F; Lesch K P
Evolutionary conserved microsatellites in the promoter region of the 5-hydroxytryptamine receptor 2C gene (HTR2C) are not associated with bipolar disorder in females.
Journal of neural transmission (Vienna, Austria : 1996) 2002;109(5-6):939-46.
2002: Gerlach M; Ukai W; Ozawa H; Riederer P
Different modes of action of catecholamine-O-methyltransferase inhibitors entacapone and tolcapone on adenylyl cyclase activity in vitro.
Journal of neural transmission (Vienna, Austria : 1996) 2002;109(5-6):789-95.
2002: Koutsilieri E; Sopper S; Scheller C; ter Meulen V; Riederer P
Parkinsonism in HIV dementia.
Journal of neural transmission (Vienna, Austria : 1996) 2002;109(5-6):767-75.
2002: Sopper S; Koutsilieri E; Scheller C; Czub S; Riederer P; ter Meulen V
Macaque animal model for HIV-induced neurological disease.
Journal of neural transmission (Vienna, Austria : 1996) 2002;109(5-6):747-66.
2002: Götz M E; Koutsilieri E; Riederer P; Ceccatelli S; Daré E
Methylmercury induces neurite degeneration in primary culture of mouse dopaminergic mesencephalic cells.
Journal of neural transmission (Vienna, Austria : 1996) 2002;109(5-6):597-605.
2002: Mössner R; Dringen R; Persico A M; Janetzky B; Okladnova O; Albert D; Götz M; Benninghoff J; Schmitt A; Gerlach M; Riederer P; Lesch K P
Increased hippocampal DNA oxidation in serotonin transporter deficient mice.
Journal of neural transmission (Vienna, Austria : 1996) 2002;109(5-6):557-65.
2002: Riederer Peter; Foley Paul; Bringmann Gerhard; Feineis Doris; Brückner Ralph; Gerlach Manfred
Biochemical and pharmacological characterization of 1-trichloromethyl-1,2,3,4-tetrahydro-beta-carboline: a biologically relevant neurotoxin?
European journal of pharmacology 2002;442(1-2):1-16.
2002: Sand P G; Schlurmann K; Luckhaus C; Götz M; Stöber G; Lesch K-P; Riederer P; Franke P; Maier W; Nöthen M M; Propping P; Fritze J; Deckert J
Estrogen receptor 1 gene (ESR1) variants in panic disorder.
American journal of medical genetics 2002;114(4):426-8.
2002: Götz M E; Wacker M; Luckhaus C; Wanek P; Tatschner T; Jellinger K; Leblhuber F; Ransmayr G; Riederer P; Eder E
Unaltered brain levels of 1,N2-propanodeoxyguanosine adducts of trans-4-hydroxy-2-nonenal in Alzheimer's disease.
Neuroscience letters 2002;324(1):49-52.
2002: Koutsilieri E; Scheller C; Sopper S; ter Meulen V; Riederer P
The pathogenesis of HIV-induced dementia.
Mechanisms of ageing and development 2002;123(8):1047-53.
2002: Koutsilieri E; Sopper S; Scheller C; ter Meulen V; Riederer P
Involvement of dopamine in the progression of AIDS Dementia Complex.
Journal of neural transmission (Vienna, Austria : 1996) 2002;109(3):399-410.
2002: Zecca Luigi; Fariello Ruggero; Riederer Peter; Sulzer David; Gatti Alberto; Tampellini Davide
The absolute concentration of nigral neuromelanin, assayed by a new sensitive method, increases throughout the life and is dramatically decreased in Parkinson's disease.
FEBS letters 2002;510(3):216-20.
2001: Wong A; Dukic-Stefanovic S; Gasic-Milenkovic J; Schinzel R; Wiesinger H; Riederer P; Münch G
Anti-inflammatory antioxidants attenuate the expression of inducible nitric oxide synthase mediated by advanced glycation endproducts in murine microglia.
The European journal of neuroscience 2001;14(12):1961-7.
2001: Kahle P J; Neumann M; Ozmen L; Müller V; Odoy S; Okamoto N; Jacobsen H; Iwatsubo T; Trojanowski J Q; Takahashi H; Wakabayashi K; Bogdanovic N; Riederer P; Kretzschmar H A; Haass C
Selective insolubility of alpha-synuclein in human Lewy body diseases is recapitulated in a transgenic mouse model.
The American journal of pathology 2001;159(6):2215-25.
2001: Zecca L; Tampellini D; Gerlach M; Riederer P; Fariello R G; Sulzer D
Substantia nigra neuromelanin: structure, synthesis, and molecular behaviour.
Molecular pathology : MP 2001;54(6):414-8.
2001: Berg D; Gerlach M; Youdim M B; Double K L; Zecca L; Riederer P; Becker G
Brain iron pathways and their relevance to Parkinson's disease.
Journal of neurochemistry 2001;79(2):225-36.
2001: Durany N; Michel T; Zöchling R; Boissl K W; Cruz-Sánchez F F; Riederer P; Thome J
Brain-derived neurotrophic factor and neurotrophin 3 in schizophrenic psychoses.
Schizophrenia research 2001;52(1-2):79-86.
2001: Schnurra I; Bernstein H G; Riederer P; Braunewell K H
The neuronal calcium sensor protein VILIP-1 is associated with amyloid plaques and extracellular tangles in Alzheimer's disease and promotes cell death and tau phosphorylation in vitro: a link between calcium sensors and Alzheimer's disease?
Neurobiology of disease 2001;8(5):900-9.
2001: Deuther-Conrad W; Loske C; Schinzel R; Dringen R; Riederer P; Münch G
Advanced glycation endproducts change glutathione redox status in SH-SY5Y human neuroblastoma cells by a hydrogen peroxide dependent mechanism.
Neuroscience letters 2001;312(1):29-32.
2001: Retz W; Thome J; Durany N; Harsányi A; Retz-Junginger P; Kornhuber J; Riederer P; Rösler M
Potential genetic markers of sporadic Alzheimer's dementia.
Psychiatric genetics 2001;11(3):115-22.
2001: Heneka M T; Wiesinger H; Dumitrescu-Ozimek L; Riederer P; Feinstein D L; Klockgether T
Neuronal and glial coexpression of argininosuccinate synthetase and inducible nitric oxide synthase in Alzheimer disease.
Journal of neuropathology and experimental neurology 2001;60(9):906-16.
2001: Harth R; Gerlach M; Riederer P; Götz M E
A highly sensitive method for the determination of protein bound 3,4-dihydroxyphenylalanine as a marker for post-translational protein hydroxylation in human tissues ex vivo.
Free radical research 2001;35(2):167-74.
2001: Ibarra C; Nedvetsky P I; Gerlach M; Riederer P; Schmidt H H
Regional and age-dependent expression of the nitric oxide receptor, soluble guanylyl cyclase, in the human brain.
Brain research 2001;907(1-2):54-60.
2001: Götz M E; Janetzky B; Pohli S; Gottschalk A; Gsell W; Tatschner T; Ransmayr G; Leblhuber F; Gerlach M; Reichmann H; Riederer P; Böning J
Chronic alcohol consumption and cerebral indices of oxidative stress: is there a link?
Alcoholism, clinical and experimental research 2001;25(5):717-25.
2001: Mössner R; Henneberg A; Schmitt A; Syagailo Y V; Grässle M; Hennig T; Simantov R; Gerlach M; Riederer P; Lesch K P
Allelic variation of serotonin transporter expression is associated with depression in Parkinson's disease.
Molecular psychiatry 2001;6(3):350-2.
2001: Reif A; Zecca L; Riederer P; Feelisch M; Schmidt H H
Nitroxyl oxidizes NADPH in a superoxide dismutase inhibitable manner.
Free radical biology & medicine 2001;30(7):803-8.
2001: Yamamoto M; Pohli S; Durany N; Ozawa H; Saito T; Boissl K W; Zöchling R; Riederer P; Böning J; Götz M E
Increased levels of calcium-sensitive adenylyl cyclase subtypes in the limbic system of alcoholics: evidence for a specific role of cAMP signaling in the human addictive brain.
Brain research 2001;895(1-2):233-7.
2001: Zecca L; Gallorini M; Schünemann V; Trautwein A X; Gerlach M; Riederer P; Vezzoni P; Tampellini D
Iron, neuromelanin and ferritin content in the substantia nigra of normal subjects at different ages: consequences for iron storage and neurodegenerative processes.
Journal of neurochemistry 2001;76(6):1766-73.
2001: Braunewell K; Riederer P; Spilker C; Gundelfinger E D; Bogerts B; Bernstein H G
Abnormal localization of two neuronal calcium sensor proteins, visinin-like proteins (vilips)-1 and -3, in neocortical brain areas of Alzheimer disease patients.
Dementia and geriatric cognitive disorders 2001;12(2):110-6.
2001: Czub S; Koutsilieri E; Sopper S; Czub M; Stahl-Hennig C; Müller J G; Pedersen V; Gsell W; Heeney J L; Gerlach M; Gosztonyi G; Riederer P; ter Meulen V
Enhancement of central nervous system pathology in early simian immunodeficiency virus infection by dopaminergic drugs.
Acta neuropathologica 2001;101(2):85-91.
2001: Yamamoto M; Pohli S; Durany N; Ozawa H; Saito T; Boissl K W; Zöchling R; Riederer P; Böning J; Götz M E
Immunoreactivity of cAMP response element binding protein is not altered in the post-mortem cerebral cortex or cerebellum of alcoholics.
Alcohol and alcoholism (Oxford, Oxfordshire) 2001;36(1):70-4.
2001: Gerlach M; Blum-Degen D; Ransmayr G; Leblhuber F; Pedersen V; Riederer P
Expression, but not activity, of neuronal nitric oxide synthase is regionally increased in the alcoholic brain.
Alcohol and alcoholism (Oxford, Oxfordshire) 2001;36(1):65-9.
2001: Koutsilieri E; Scheller C; Sopper S; Götz M E; Gerlach M; Meulen V; Riederer P
Selegiline completely restores choline acetyltransferase activity deficits in simian immunodeficiency infection.
European journal of pharmacology 2001;411(1-2):R1-R2.
2001: Rubie C; Schmidt F; Knapp M; Sprandel J; Wiegand C; Meyer J; Jungkunz G; Riederer P; Stöber G
The human dopamine transporter gene: the 5'-flanking region reveals five diallelic polymorphic sites in a Caucasian population sample.
Neuroscience letters 2001;297(2):125-8.
2001: Harth R; Gerlach M; Riederer P; Götz M E
A sensitive procedure for the determination of protein bound 3,4-dihydroxyphenyl-alanine as a marker for posttranslational protein hydroxylation in human frontal cortex, liver, and red blood cells.
Advances in experimental medicine and biology 2001;500():517-9.
2001: Kupsch A; Sautter J; Götz M E; Breithaupt W; Schwarz J; Youdim M B; Riederer P; Gerlach M; Oertel W H
Monoamine oxidase-inhibition and MPTP-induced neurotoxicity in the non-human primate: comparison of rasagiline (TVP 1012) with selegiline.
Journal of neural transmission (Vienna, Austria : 1996) 2001;108(8-9):985-1009.
2001: Dukic-Stefanovic S; Schinzel R; Riederer P; Münch G
AGES in brain ageing: AGE-inhibitors as neuroprotective and anti-dementia drugs?
Biogerontology 2001;2(1):19-34.
2001: Riederer P; Reichmann H; Janetzky B; Sian J; Lesch K P; Lange K W; Double K L; Nagatsu T; Gerlach M
Neural degeneration in Parkinson's disease.
Advances in neurology 2001;86():125-36.
2001: Koutsilieri E; ter Meulen V; Riederer P
Neurotransmission in HIV associated dementia: a short review.
Journal of neural transmission (Vienna, Austria : 1996) 2001;108(6):767-75.
2001: Sand P; Kleinschnitz M; Vogel P; Kavvadias D; Schreier P; Riederer P
Naturally occurring benzodiazepines may codetermine chronotypes.
Journal of neural transmission (Vienna, Austria : 1996) 2001;108(6):747-53.
2001: Shichinohe S; Ozawa H; Hashimoto E; Tatschner T; Riederer P; Saito T
Changes in the cAMP-related signal transduction mechanism in postmortem human brains of heroin addicts.
Journal of neural transmission (Vienna, Austria : 1996) 2001;108(3):335-47.
2001: Gerlach M; Xiao A Y; Kuhn W; Lehnfeld R; Waldmeier P; Sontag K H; Riederer P
The central catechol-O-methyltransferase inhibitor tolcapone increases striatal hydroxyl radical production in L-DOPA/carbidopa treated rats.
Journal of neural transmission (Vienna, Austria : 1996) 2001;108(2):189-204.
2000: Sand P G; Godau C; Riederer P; Peters C; Franke P; Nöthen M M; Stöber G; Fritze J; Maier W; Propping P; Lesch K P; Riess O; Sander T; Beckmann H; Deckert J
Exonic variants of the GABA(B) receptor gene and panic disorder.
Psychiatric genetics 2000;10(4):191-4.
2000: Münch G; Lüth H J; Wong A; Arendt T; Hirsch E; Ravid R; Riederer P
Crosslinking of alpha-synuclein by advanced glycation endproducts--an early pathophysiological step in Lewy body formation?
Journal of chemical neuroanatomy 2000;20(3-4):253-7.
2000: Durany N; Michel T; Kurt J; Cruz-Sánchez F F; Cervás-Navarro J; Riederer P
Brain-derived neurotrophic factor and neurotrophin-3 levels in Alzheimer's disease brains.
International journal of developmental neuroscience : the official journal of the International Society for Developmental Neuroscience 2000;18(8):807-13.
2000: Yamamoto M; Götz M E; Ozawa H; Luckhaus C; Saito T; Rösler M; Riederer P
Hippocampal level of neural specific adenylyl cyclase type I is decreased in Alzheimer's disease.
Biochimica et biophysica acta 2000;1535(1):60-8.
2000: Double K L; Zecca L; Costi P; Mauer M; Griesinger C; Ito S; Ben-Shachar D; Bringmann G; Fariello R G; Riederer P; Gerlach M
Structural characteristics of human substantia nigra neuromelanin and synthetic dopamine melanins.
Journal of neurochemistry 2000;75(6):2583-9.
2000: Cruz-Sánchez F F; Durany N; Thome J; Riederer P; Zambón D
Correlation between Apolipoprotein-E polymorphism and Alzheimer's disease pathology.
Journal of Alzheimer's disease : JAD 2000;2(3-4):223-9.
2000: Riederer P; Sian J; Gerlach M
Is there neuroprotection in Parkinson syndrome?
Journal of neurology 2000;247 Suppl 4():IV/8-11.
2000: Riederer P; Brücke T; Buhmann C; Müller T; Schwartz A; Storch A; Winner B
Workshop II: "neuroprotection"--the Lugano consensus.
Journal of neurology 2000;247 Suppl 4():IV/36-7.
2000: Durany N; Ravid R; Riederer P; Cruz-Sánchez F F
Increased frequency of the alpha-1-antichymotrypsin T allele in cerebral amyloid angiopathy.
Neuropathology : official journal of the Japanese Society of Neuropathology 2000;20(3):184-9.
2000: Koutsilieri E; Czub S; Scheller C; Sopper S; Tatschner T; Stahl-Hennig C; ter Meulen V; Riederer P
Brain choline acetyltransferase reduction in SIV infection. An index of early dementia?
Neuroreport 2000;11(11):2391-3.
2000: Sand P; Lesch K P; Catalano M; Bosi M; Syagailo Y V; Okladnova O; Di Bella D; Maffei P; Heils A; Friess F; Politi E; Nöthen M M; Franke P; Stöber G; Fritze J; Maier W; Propping P; Beckmann H; Bellodi L; Riederer P; Deckert J
Polymorphic MAO-A and 5-HT-transporter genes: analysis of interactions in panic disorder.
The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry 2000;1(3):147-50.
2000: Loske C; Gerdemann A; Schepl W; Wycislo M; Schinzel R; Palm D; Riederer P; Münch G
Transition metal-mediated glycoxidation accelerates cross-linking of beta-amyloid peptide.
European journal of biochemistry / FEBS 2000;267(13):4171-8.
2000: Durany N; Riederer P; Cruz-Sánchez F F
Apolipoprotein E genotype in Spanish schizophrenic patients.
Psychiatric genetics 2000;10(2):73-7.
2000: Durany N; Zöchling R; Boissl K W; Paulus W; Ransmayr G; Tatschner T; Danielczyk W; Jellinger K; Deckert J; Riederer P
Human post-mortem striatal alpha4beta2 nicotinic acetylcholine receptor density in schizophrenia and Parkinson's syndrome.
Neuroscience letters 2000;287(2):109-12.
2000: Foley P; Riederer P
Influence of neurotoxins and oxidative stress on the onset and progression of Parkinson's disease.
Journal of neurology 2000;247 Suppl 2():II82-94.
2000: Wüllner U; Weller M; Kornhuber J; Bornemann A; Schulz J B; Riederer P; Klockgether T
Altered expression of calcium- and apoptosis-regulating proteins in multiple system atrophy Purkinje cells.
Movement disorders : official journal of the Movement Disorder Society 2000;15(2):269-75.
2000: Kavvadias D; Abou-Mandour A A; Czygan F C; Beckmann H; Sand P; Riederer P; Schreier P
Identification of benzodiazepines in Artemisia dracunculus and Solanum tuberosum rationalizing their endogenous formation in plant tissue.
Biochemical and biophysical research communications 2000;269(1):290-5.
2000: Heim C; Zhang J; Lan J; Sieklucka M; Kurz T; Riederer P; Gerlach M; Sontag K H
Cerebral oligaemia episode triggers free radical formation and late cognitive deficiencies.
The European journal of neuroscience 2000;12(2):715-25.
2000: Foley P; Gerlach M; Youdim M B; Riederer P
MAO-B inhibitors: multiple roles in the therapy of neurodegenerative disorders?
Parkinsonism & related disorders 2000;6(1):25-47.
2000: Xiao A Y; Double K; Heinemann T; Rausch W D; Riederer P; Gerlach M
The industrial chemical Tinuvin 123 does not induce dopaminergic neurotoxicity in C57Bl/6 mice.
Neuroscience letters 2000;278(3):165-8.
2000: Gerlach M; Double K L; Youdim M B; Riederer P
Strategies for the protection of dopaminergic neurons against neurotoxicity.
Neurotoxicity research 2000;2(2-3):99-114.
2000: Scheller C; Sopper S; Jassoy C; ter Meulen V; Riederer P; Koutsilieri E
Dopamine activates HIV in chronically infected T lymphoblasts.
Journal of neural transmission (Vienna, Austria : 1996) 2000;107(12):1483-9.
2000: Double K L; Gerlach M; Youdim M B; Riederer P
Impaired iron homeostasis in Parkinson's disease.
Journal of neural transmission. Supplementum 2000;(60):37-58.
2000: Mössner R; Schmitt A; Syagailo Y; Gerlach M; Riederer P; Lesch K P
The serotonin transporter in Alzheimer's and Parkinson's disease.
Journal of neural transmission. Supplementum 2000;(60):345-50.
2000: Foley P; Riederer P
The motor circuit of the human basal ganglia reconsidered.
Journal of neural transmission. Supplementum 2000;(58):97-110.
2000: Savvateeva E; Popov A; Kamyshev N; Bragina J; Heisenberg M; Senitz D; Kornhuber J; Riederer P
Age-dependent memory loss, synaptic pathology and altered brain plasticity in the Drosophila mutant cardinal accumulating 3-hydroxykynurenine.
Journal of neural transmission (Vienna, Austria : 1996) 2000;107(5):581-601.
2000: Sand P; Kavvadias D; Feineis D; Riederer P; Schreier P; Kleinschnitz M; Czygan F C; Abou-Mandour A; Bringmann G; Beckmann H
Naturally occurring benzodiazepines: current status of research and clinical implications.
European archives of psychiatry and clinical neuroscience 2000;250(4):194-202.
2000: Götz M E; Gerstner A; Harth R; Dirr A; Janetzky B; Kuhn W; Riederer P; Gerlach M
Altered redox state of platelet coenzyme Q10 in Parkinson's disease.
Journal of neural transmission (Vienna, Austria : 1996) 2000;107(1):41-8.
1999: Czygan M; Hallensleben W; Hofer M; Pollak S; Sauder C; Bilzer T; Blümcke I; Riederer P; Bogerts B; Falkai P; Schwarz M J; Masliah E; Staeheli P; Hufert F T; Lieb K
Borna disease virus in human brains with a rare form of hippocampal degeneration but not in brains of patients with common neuropsychiatric disorders.
The Journal of infectious diseases 1999;180(5):1695-9.
1999: Czub M; Czub S; Gosztonyi G; Koutsilieri E; Sopper S; Müller J G; Gerlach M; Riederer P; ter Meulen V
Effects of Selegiline in a retroviral rat model for neurodegenerative disease.
Journal of neurovirology 1999;5(5):458-64.
1999: Münch G; Schicktanz D; Behme A; Gerlach M; Riederer P; Palm D; Schinzel R
Amino acid specificity of glycation and protein-AGE crosslinking reactivities determined with a dipeptide SPOT library.
Nature biotechnology 1999;17(10):1006-10.
1999: Becker G; Berg D; Rausch W D; Lange H K; Riederer P; Reiners K
Increased tissue copper and manganese content in the lentiform nucleus in primary adult-onset dystonia.
Annals of neurology 1999;46(2):260-3.
1999: Berg D; Grote C; Rausch W D; Mäurer M; Wesemann W; Riederer P; Becker G
Iron accumulation in the substantia nigra in rats visualized by ultrasound.
Ultrasound in medicine & biology 1999;25(6):901-4.
1999: Kornhuber J; Jellinger K; Wiltfang J; Leblhuber F; Riederer P
The N-methyl-D-aspartate receptor channel blocker amantadine does not cause histopathological alterations in human brain tissue.
Acta neuropathologica 1999;98(1):85-90.
1999: Blum-Degen D; Heinemann T; Lan J; Pedersen V; Leblhuber F; Paulus W; Riederer P; Gerlach M
Characterization and regional distribution of nitric oxide synthase in the human brain during normal ageing.
Brain research 1999;834(1-2):128-35.
1999: Neumann A; Schinzel R; Palm D; Riederer P; Münch G
High molecular weight hyaluronic acid inhibits advanced glycation endproduct-induced NF-kappaB activation and cytokine expression.
FEBS letters 1999;453(3):283-7.
1999: Kornhuber J; Schultz A; Wiltfang J; Meineke I; Gleiter C H; Zöchling R; Boissl K W; Leblhuber F; Riederer P
Persistence of haloperidol in human brain tissue.
The American journal of psychiatry 1999;156(6):885-90.
1999: Elstner M; Denke A; Gsell W; Elstner E F; Riederer P; Gerlach M
Pro- and antioxidative properties of cortical tissue preparations from human brain exhibiting NMDA-receptor characteristics.
Zeitschrift für Naturforschung. C, Journal of biosciences 1999;54(5-6):438-45.
1999: Sohma H; Hashimoto E; Shirasaka T; Tsunematsu R; Ozawa H; Boissl K W; Böning J; Riederer P; Saito T
Quantitative reduction of type I adenylyl cyclase in human alcoholics.
Biochimica et biophysica acta 1999;1454(1):11-8.
1999: Götz M E; Ahlbom E; Zhivotovsky B; Blum-Degen D; Oettel M; Römer W; Riederer P; Orrenius S; Ceccatelli S
Radical scavenging compound J 811 inhibits hydrogen peroxide-induced death of cerebellar granule cells.
Journal of neuroscience research 1999;56(4):420-6.
1999: Wüllner U; Kornhuber J; Weller M; Schulz J B; Löschmann P A; Riederer P; Klockgether T
Cell death and apoptosis regulating proteins in Parkinson's disease--a cautionary note.
Acta neuropathologica 1999;97(4):408-12.
1999: Yamamoto-Sasaki M; Ozawa H; Saito T; Rösler M; Riederer P
Impaired phosphorylation of cyclic AMP response element binding protein in the hippocampus of dementia of the Alzheimer type.
Brain research 1999;824(2):300-3.
1999: Okladnova O; Syagailo Y V; Tranitz M; Riederer P; Stöber G; Mössner R; Lesch K P
Functional characterization of the human PAX3 gene regulatory region.
Genomics 1999;57(1):110-9.
1999: Thome J; Weijers H G; Wiesbeck G A; Sian J; Nara K; Böning J; Riederer P
Dopamine D3 receptor gene polymorphism and alcohol dependence: relation to personality rating.
Psychiatric genetics 1999;9(1):17-21.
1999: Bernstein H G; Ansorge S; Riederer P; Reiser M; Frölich L; Bogerts B
Insulin-degrading enzyme in the Alzheimer's disease brain: prominent localization in neurons and senile plaques.
Neuroscience letters 1999;263(2-3):161-4.
1999: Koutsilieri E; Sopper S; Heinemann T; Scheller C; Lan J; Stahl-Hennig C; ter Meulen V; Riederer P; Gerlach M
Involvement of microglia in cerebrospinal fluid glutamate increase in SIV-infected rhesus monkeys (Macaca mulatta).
AIDS research and human retroviruses 1999;15(5):471-7.
1999: Savvateeva E V; Popov A V; Kamyshev N G; Iliadi K G; Bragina J V; Heisenberg M; Kornhuber J; Riederer P
Age-dependent changes in memory and mushroom bodies in the Drosophila mutant vermilion deficient in the kynurenine pathway of tryptophan metabolism.
Rossiiskii fiziologicheskii zhurnal imeni I.M. Sechenova / Rossiiskaia akademiia nauk 1999;85(1):167-83.
1999: Frölich L; Blum-Degen D; Riederer P; Hoyer S
A disturbance in the neuronal insulin receptor signal transduction in sporadic Alzheimer's disease.
Annals of the New York Academy of Sciences 1999;893():290-3.
1999: Durany N; Münch G; Michel T; Riederer P
Investigations on oxidative stress and therapeutical implications in dementia.
European archives of psychiatry and clinical neuroscience 1999;249 Suppl 3():68-73.
1999: Lesch K P; Jatzke S; Meyer J; Stöber G; Okladnova O; Mössner R; Riederer P
Mosaicism for a serotonin transporter gene promoter-associated deletion: decreased recombination in depression.
Journal of neural transmission (Vienna, Austria : 1996) 1999;106(11-12):1223-30.
1999: Ozawa H; Ukai W; Kornhuber J; Yamaguchi T; Froelich L; Ikeda H; Saito T; Riederer P
Postnatal ontogeny of GTP binding protein in the human frontal cortex.
Life sciences 1999;65(22):2315-23.
1999: Sian J; Gerlach M; Youdim M B; Riederer P
Parkinson's disease: a major hypokinetic basal ganglia disorder.
Journal of neural transmission (Vienna, Austria : 1996) 1999;106(5-6):443-76.
1999: Double K L; Riederer P F; Gerlach M
Role of iron in 6-hydroxydopamine neurotoxicity.
Advances in neurology 1999;80():287-96.
1999: Gerlach M; Blum-Degen D; Lan J; Riederer P
Nitric oxide in the pathogenesis of Parkinson's disease.
Advances in neurology 1999;80():239-45.
1999: Gerlach M; Riederer P F
Time sequences of dopaminergic cell death in Parkinson's disease: indications for neuroprotective studies.
Advances in neurology 1999;80():219-25.
1999: Foley P; Riederer P
Pathogenesis and preclinical course of Parkinson's disease.
Journal of neural transmission. Supplementum 1999;56():31-74.
1998: Wodarz N; Rothenhöfer C; Fischer R; Stöber G; Kiehl B; Jungkunz G; Riederer P; Klein H E
Peripheral-type benzodiazepine receptors in diagnostic subtypes of schizophrenic patients.
Psychiatry research 1998;81(3):363-9.
1998: Gerlach M; Xiao A Y; Heim C; Lan J; God R; Feineis D; Bringmann G; Riederer P; Sontag K H
1-Trichloromethyl-1,2,3,4-tetrahydro-beta-carboline increases extracellular serotonin and stimulates hydroxyl radical production in rats.
Neuroscience letters 1998;257(1):17-20.
1998: Okladnova O; Syagailo Y V; Mössner R; Riederer P; Lesch K P
Regulation of PAX-6 gene transcription: alternate promoter usage in human brain.
Brain research. Molecular brain research 1998;60(2):177-92.
1998: Blum-Degen D; Haas M; Pohli S; Harth R; Römer W; Oettel M; Riederer P; Götz M E
Scavestrogens protect IMR 32 cells from oxidative stress-induced cell death.
Toxicology and applied pharmacology 1998;152(1):49-55.
1998: Münch G; Gerlach M; Sian J; Wong A; Riederer P
Advanced glycation end products in neurodegeneration: more than early markers of oxidative stress?
Annals of neurology 1998;44(3 Suppl 1):S85-8.
1998: Sian J; Hensiek R; Senitz D; Muench G; Jellinger K; Riederer P; Gerlach M
A novel technique for the isolation of Lewy bodies in brain.
Acta neuropathologica 1998;96(2):111-5.
1998: Künig G; Niedermeyer B; Deckert J; Gsell W; Ransmayr G; Riederer P
Inhibition of [3H]alpha-amino-3-hydroxy-5-methyl-4-isoxazole-propionic acid [AMPA] binding by the anticonvulsant valproate in clinically relevant concentrations: an autoradiographic investigation in human hippocampus.
Epilepsy research 1998;31(2):153-7.
1998: Okladnova O; Syagailo Y V; Tranitz M; Stöber G; Riederer P; Mössner R; Lesch K P
A promoter-associated polymorphic repeat modulates PAX-6 expression in human brain.
Biochemical and biophysical research communications 1998;248(2):402-5.
1998: Münch G; Cunningham A M; Riederer P; Braak E
Advanced glycation endproducts are associated with Hirano bodies in Alzheimer's disease.
Brain research 1998;796(1-2):307-10.
1998: Double K L; Maywald M; Schmittel M; Riederer P; Gerlach M
In vitro studies of ferritin iron release and neurotoxicity.
Journal of neurochemistry 1998;70(6):2492-9.
1998: Hashimoto E; Frölich L; Ozawa H; Saito T; Maurer K; Böning J; Takahata N; Riederer P
Reduced immunoreactivity of type I adenylyl cyclase in the postmortem brains of alcoholics.
Alcoholism, clinical and experimental research 1998;22(3 Suppl):88S-92S.
1998: Shichinohe S; Ozawa H; Saito T; Hashimoto E; Lang C; Riederer P; Takahata N
Differential alteration of adenylyl cyclase subtypes I, II, and V/VI in postmortem human brains of heroin addicts.
Alcoholism, clinical and experimental research 1998;22(3 Suppl):84S-87S.
1998: Odagaki Y; Nishi N; Ozawa H; Saito T; Takahata N; Riederer P; Koyama T
Measurement of receptor-mediated functional activation of G proteins in postmortem human brain membranes.
Brain research 1998;789(1):84-91.
1998: Deckert J; Abel F; Künig G; Hartmann J; Senitz D; Maier H; Ransmayr G; Riederer P
Loss of human hippocampal adenosine A1 receptors in dementia: evidence for lack of specificity.
Neuroscience letters 1998;244(1):1-4.
1998: Gerlach M; Koutsilieri E; Riederer P
N-methyl-(R)-salsolinol and its relevance to Parkinson's disease.
Lancet 1998;351(9106):850-1.
1998: Götz M E; Fischer P; Gsell W; Riederer P; Streifler M; Simanyi M; Müller F; Danielczyk W
Platelet monoamine oxidase B activity in dementia. A 4-year follow-up.
Dementia and geriatric cognitive disorders 1998;9(2):74-7.
1998: Meyer J; Wiedemann P; Okladnova O; Brüss M; Staab T; Stöber G; Riederer P; Bönisch H; Lesch K P
Cloning and functional characterization of the human norepinephrine transporter gene promoter.
Journal of neural transmission (Vienna, Austria : 1996) 1998;105(10-12):1341-50.
1998: Loske C; Neumann A; Cunningham A M; Nichol K; Schinzel R; Riederer P; Münch G
Cytotoxicity of advanced glycation endproducts is mediated by oxidative stress.
Journal of neural transmission (Vienna, Austria : 1996) 1998;105(8-9):1005-15.
1998: Frölich L; Dirr A; Götz M E; Gsell W; Reichmann H; Riederer P; Maurer K
Acetylcholine in human CSF: methodological considerations and levels in dementia of Alzheimer type.
Journal of neural transmission (Vienna, Austria : 1996) 1998;105(8-9):961-73.
1998: Retz W; Gsell W; Münch G; Rösler M; Riederer P
Free radicals in Alzheimer's disease.
Journal of neural transmission. Supplementum 1998;54():221-36.
1998: Rösler M; Retz W; Thome J; Riederer P
Free radicals in Alzheimer's dementia: currently available therapeutic strategies.
Journal of neural transmission. Supplementum 1998;54():211-9.
1998: Münch G; Schinzel R; Loske C; Wong A; Durany N; Li J J; Vlassara H; Smith M A; Perry G; Riederer P
Alzheimer's disease--synergistic effects of glucose deficit, oxidative stress and advanced glycation endproducts.
Journal of neural transmission (Vienna, Austria : 1996) 1998;105(4-5):439-61.
1998: Frölich L; Blum-Degen D; Bernstein H G; Engelsberger S; Humrich J; Laufer S; Muschner D; Thalheimer A; Türk A; Hoyer S; Zöchling R; Boissl K W; Jellinger K; Riederer P
Brain insulin and insulin receptors in aging and sporadic Alzheimer's disease.
Journal of neural transmission (Vienna, Austria : 1996) 1998;105(4-5):423-38.
1998: Stöber G; Jatzke S; Heils A; Jungkunz G; Fuchs E; Knapp M; Riederer P; Lesch K P
Susceptibility for schizophrenia is not influenced by a functional insertion/deletion variant in the promoter of the serotonin transporter gene.
European archives of psychiatry and clinical neuroscience 1998;248(2):82-6.
1998: Bengel D; Balling U; Stöber G; Heils A; Li S H; Ross C A; Jungkunz G; Franzek E; Beckmann H; Riederer P; Lesch K P
Distribution of the B33 CTG repeat polymorphism in a subtype of schizophrenia.
European archives of psychiatry and clinical neuroscience 1998;248(2):78-81.
1998: Stöber G; Jatzke S; Heils A; Jungkunz G; Knapp M; Mössner R; Riederer P; Lesch K P
Insertion/deletion variant (-141C Ins/Del) in the 5' regulatory region of the dopamine D2 receptor gene: lack of association with schizophrenia and bipolar affective disorder. Short communication.
Journal of neural transmission (Vienna, Austria : 1996) 1998;105(1):101-9.
1998: Thome J; Foley P; Riederer P
Neurotrophic factors and the maldevelopmental hypothesis of schizophrenic psychoses. Review article.
Journal of neural transmission (Vienna, Austria : 1996) 1998;105(1):85-100.
1998: Eder U; Leitner B; Kirchmair R; Pohl P; Jobst K A; Smith A D; Málly J; Benzer A; Riederer P; Reichmann H; Saria A; Winkler H
Levels and proteolytic processing of chromogranin A and B and secretogranin II in cerebrospinal fluid in neurological diseases.
Journal of neural transmission (Vienna, Austria : 1996) 1998;105(1):39-51.
1998: Götz M E; Breithaupt W; Sautter J; Kupsch A; Schwarz J; Oertel W H; Youdim M B; Riederer P; Gerlach M
Chronic TVP-1012 (rasagiline) dose--activity response of monoamine oxidases A and B in the brain of the common marmoset.
Journal of neural transmission. Supplementum 1998;52():271-8.
1997: Koutsilieri E; Götz M E; Sopper S; Stahl-Hennig C; Czub M; ter Meulen V; Riederer P
Monoamine metabolite levels in CSF of SIV-infected rhesus monkeys (Macaca mulatta).
Neuroreport 1997;8(17):3833-6.
1997: Weisser M; Vieth M; Stolte M; Riederer P; Pfeuffer R; Leblhuber F; Spiteller G
Dramatic increase of alpha-hydroxyaldehydes derived from plasmalogens in the aged human brain.
Chemistry and physics of lipids 1997;90(1-2):135-42.
1997: Becker T; Becker G; Seufert J; Hofmann E; Lange K W; Naumann M; Lindner A; Reichmann H; Riederer P; Beckmann H; Reiners K
Parkinson's disease and depression: evidence for an alteration of the basal limbic system detected by transcranial sonography.
Journal of neurology, neurosurgery, and psychiatry 1997;63(5):590-6.
1997: Koutsilieri E; Götz M E; Sopper S; Sauer U; Demuth M; ter Meulen V; Riederer P
Regulation of glutathione and cell toxicity following exposure to neurotropic substances and human immunodeficiency virus-1 in vitro.
Journal of neurovirology 1997;3(5):342-9.
1997: Münch G; Keis R; Wessels A; Riederer P; Bahner U; Heidland A; Niwa T; Lemke H D; Schinzel R
Determination of advanced glycation end products in serum by fluorescence spectroscopy and competitive ELISA.
European journal of clinical chemistry and clinical biochemistry : journal of the Forum of European Clinical Chemistry Societies 1997;35(9):669-77.
1997: Lange K W; Kornhuber J; Riederer P
Dopamine/glutamate interactions in Parkinson's disease.
Neuroscience and biobehavioral reviews 1997;21(4):393-400.
1997: Thome J; Durany N; Palomo A; Foley P; Harsányi A; Baumer A; Hashimoto E; Cruz-Sánchez F F; Riederer P
Variants in neurotrophic factor genes and schizophrenic psychoses: no associations in a Spanish population.
Psychiatry research 1997;71(1):1-5.
1997: Heidrich A; Rösler M; Riederer P
[Pharmacotherapy of Alzheimer dementia: therapy of cognitive symptoms--new results of clinical studies]
Fortschritte der Neurologie-Psychiatrie 1997;65(3):108-21.
1997: Thome J; Nara K; Foley P; Gsell W; Wiesbeck G A; Böning J; Riederer P
Time course of manganese superoxide dismutase concentrations in serum of alcohol-dependent patients during abstinence.
Drug and alcohol dependence 1997;44(2-3):151-5.
1997: Gerlach M; Double K; Riederer P; Hirsch E; Jellinger K; Jenner P; Trautwein A; Youdim M B
Iron in the Parkinsonian substantia nigra.
Movement disorders : official journal of the Movement Disorder Society 1997;12(2):258-60.
1997: Münch G; Thome J; Foley P; Schinzel R; Riederer P
Advanced glycation endproducts in ageing and Alzheimer's disease.
Brain research. Brain research reviews 1997;23(1-2):134-43.
1997: Münch G; Mayer S; Michaelis J; Hipkiss A R; Riederer P; Müller R; Neumann A; Schinzel R; Cunningham A M
Influence of advanced glycation end-products and AGE-inhibitors on nucleation-dependent polymerization of beta-amyloid peptide.
Biochimica et biophysica acta 1997;1360(1):17-29.
1997: Thome J; Zhang J; Davids E; Foley P; Weijers H G; Wiesbeck G A; Böning J; Riederer P; Gerlach M
Evidence for increased oxidative stress in alcohol-dependent patients provided by quantification of in vivo salicylate hydroxylation products.
Alcoholism, clinical and experimental research 1997;21(1):82-5.
1997: Thome J; Foley P; Gsell W; Davids E; Wodarz N; Wiesbeck G A; Böning J; Riederer P
Increased concentrations of manganese superoxide dismutase in serum of alcohol-dependent patients.
Alcohol and alcoholism (Oxford, Oxfordshire) 1997;32(1):65-9.
1997: Youdim M B; Riederer P
Understanding Parkinson's disease.
Scientific American 1997;276(1):52-9.
1997: Lesch K P; Meyer J; Glatz K; Flügge G; Hinney A; Hebebrand J; Klauck S M; Poustka A; Poustka F; Bengel D; Mössner R; Riederer P; Heils A
The 5-HT transporter gene-linked polymorphic region (5-HTTLPR) in evolutionary perspective: alternative biallelic variation in rhesus monkeys. Rapid communication.
Journal of neural transmission (Vienna, Austria : 1996) 1997;104(11-12):1259-66.
1997: Thome J; Nara K; Foley P; Michel T; Gsell W; Retz W; Rosler M; Riederer P
Ciliary neurotrophic factor (CNTF) genotypes: influence on choline acetyltransferase (ChAT) and acetylcholine esterase (AChE) activities and neurotrophin 3 (NT3) concentration in human post mortem brain tissue.
Journal für Hirnforschung 1997;38(4):443-51.
1997: Gsell W; Strein I; Krause U; Riederer P
Neurochemical abnormalities in Alzheimer's disease and Parkinson's disease--a comparative review.
Journal of neural transmission. Supplementum 1997;51():145-59.
1997: Yamamoto M; Ozawa H; Saito T; Hatta S; Riederer P; Takahata N
Ca2+/CaM-sensitive adenylyl cyclase activity is decreased in the Alzheimer's brain: possible relation to type I adenylyl cyclase.
Journal of neural transmission (Vienna, Austria : 1996) 1997;104(6-7):721-32.
1997: Thome J; Jönsson E; Foley P; Harsányi A; Sedvall G; Riederer P
Ciliary neurotrophic factor null mutation and schizophrenia in a Swedish population.
Psychiatric genetics 1997;7(2):79-82.
1997: Lesch K P; Balling U; Seemann M; Teufel A; Bengel D; Heils A; Godeck P; Riederer P
Molecular heterogeneity of neurotransporters: implications for neurodegeneration.
Journal of neural transmission. Supplementum 1997;49():155-67.
1997: Carlsson A; Riederer P; Stern G
Walther Birkmayer--the man behind the name.
Journal of neural transmission (Vienna, Austria : 1996) 1997;104(2-3):V-VIII.
1997: Fischer P; Götz M E; Danielczyk W; Gsell W; Riederer P
Blood transferrin and ferritin in Alzheimer's disease.
Life sciences 1997;60(25):2273-8.
1997: Rupprecht M; Salzer B; Raum B; Hornstein O P; Koch H U; Riederer P; Sofic E; Rupprecht R
Physical stress-induced secretion of adrenal and pituitary hormones in patients with atopic eczema compared with normal controls.
Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association 1997;105(1):39-45.
1997: Thome J; Gsell W; Rösler M; Kornhuber J; Frölich L; Hashimoto E; Zielke B; Wiesbeck G A; Riederer P
Oxidative-stress associated parameters (lactoferrin, superoxide dismutases) in serum of patients with Alzheimer's disease.
Life sciences 1997;60(1):13-9.
1996: Mogi M; Harada M; Kondo T; Mizuno Y; Narabayashi H; Riederer P; Nagatsu T
The soluble form of Fas molecule is elevated in parkinsonian brain tissues.
Neuroscience letters 1996;220(3):195-8.
1996: Durany N; Thome J; Palomo A; Foley P; Riederer P; Cruz-Sánchez F F
Homozygosity at the dopamine D3 receptor gene in schizophrenic patients.
Neuroscience letters 1996;220(3):151-4.
1996: Hashimoto E; Frölich L; Ozawa H; Saito T; Shichinohe S; Takahata N; Riederer P
Alteration of glutamyltranspeptidase binding proteins in postmortem brains of heroin addicts.
Alcoholism, clinical and experimental research 1996;20(9 Suppl):301A-304A.
1996: Gerlach M; Youdim M B; Riederer P
Pharmacology of selegiline.
Neurology 1996;47(6 Suppl 3):S137-45.
1996: Yamamoto M; Ozawa H; Saito T; Frölich L; Riederer P; Takahata N
Reduced immunoreactivity of adenylyl cyclase in dementia of the Alzheimer type.
Neuroreport 1996;7(18):2965-70.
1996: Thome J; Kornhuber J; Münch G; Schinzel R; Taneli Y; Zielke B; Rösler M; Riederer P
[New hypothesis on etiopathogenesis of Alzheimer syndrome. Advanced glycation end products (AGEs)]
Der Nervenarzt 1996;67(11):924-9.
1996: Kupsch A; Sautter J; Schwarz J; Riederer P; Gerlach M; Oertel W H
1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity in non-human primates is antagonized by pretreatment with nimodipine at the nigral, but not at the striatal level.
Brain research 1996;741(1-2):185-96.
1996: Gerlach M; Gsell W; Kornhuber J; Jellinger K; Krieger V; Pantucek F; Vock R; Riederer P
A post mortem study on neurochemical markers of dopaminergic, GABA-ergic and glutamatergic neurons in basal ganglia-thalamocortical circuits in Parkinson syndrome.
Brain research 1996;741(1-2):142-52.
1996: Mogi M; Harada M; Kondo T; Mizuno Y; Narabayashi H; Riederer P; Nagatsu T
bcl-2 protein is increased in the brain from parkinsonian patients.
Neuroscience letters 1996;215(2):137-9.
1996: Koutsilieri E; Kornhuber J; Degen H J; Lesch K P; Sopper S; ter Meulen V; Riederer P
U-373 MG glioblastoma and IMR-32 neuroblastoma cell lines express the dopamine and vesicular monoamine transporters.
Journal of neuroscience research 1996;45(3):269-75.
1996: Thome J; Baumer A; Harsányi A; Foley P; Kornhuber J; Wiesbeck G A; Rösler M; Riederer P
The Gly/Glu polymorphism of the neurotrophin 3 gene: allele frequencies in a Caucasian population and relevance for psychiatric disorders.
Neuroreport 1996;7(10):1623-6.
1996: Lesch K P; Heils A; Riederer P
The role of neurotransporters in excitotoxicity, neuronal cell death, and other neurodegenerative processes.
Journal of molecular medicine (Berlin, Germany) 1996;74(7):365-78.
1996: Koutsilieri E; Chen T S; Rausch W D; Riederer P
Selegiline is neuroprotective in primary brain cultures treated with 1-methyl-4-phenylpyridinium.
European journal of pharmacology 1996;306(1-3):181-6.
1996: Wodarz N; Wiesbeck G A; Rommelspacher H; Riederer P; Böning J
Excretion of beta-carbolines harman and norharman in 24-hour urine of chronic alcoholics during withdrawal and controlled abstinence.
Alcoholism, clinical and experimental research 1996;20(4):706-10.
1996: Sopper S; Demuth M; Stahl-Hennig C; Hunsmann G; Plesker R; Coulibaly C; Czub S; Ceska M; Koutsilieri E; Riederer P; Brinkmann R; Katz M; ter Meulen V
The effect of simian immunodeficiency virus infection in vitro and in vivo on the cytokine production of isolated microglia and peripheral macrophages from rhesus monkey.
Virology 1996;220(2):320-9.
1996: Heils A; Teufel A; Petri S; Stöber G; Riederer P; Bengel D; Lesch K P
Allelic variation of human serotonin transporter gene expression.
Journal of neurochemistry 1996;66(6):2621-4.
1996: Thome J; Durany N; Harsányi A; Foley P; Palomo A; Kornhuber J; Weijers H G; Baumer A; Rösler M; Cruz-Sánchez F F; Beckmann H; Riederer P
A null mutation allele in the CNTF gene and schizophrenic psychoses.
Neuroreport 1996;7(8):1413-6.
1996: Wodarz N; Fritze J; Riederer P
3H-spiperone binding to peripheral mononuclear cells in psychiatric in-patients.
Progress in neuro-psychopharmacology & biological psychiatry 1996;20(3):459-70.
1996: Retz W; Kornhuber J; Riederer P
[Neurotransmitters and ontogenesis of the central nervous system in the human]
Zeitschrift für Kinder- und Jugendpsychiatrie und Psychotherapie 1996;24(1):34-43.
1996: Gerlach M; Riederer P
[Pathogenesis and neuroprotective therapy trial in chronic degenerative diseases. Status of antioxidants]
Medizinische Klinik (Munich, Germany : 1983) 1996;91(3):163-70.
1996: Gerlach M; Riederer P; Vogt H
Effect of adding selegeline to levodopa in early, mild Parkinson's disease. "On treatment" rather than intention to treat analysis should have been used.
BMJ (Clinical research ed.) 1996;312(7032):704; author reply 704-5.
1996: Thome J; Kornhuber J; Baumer A; Rösler M; Beckmann H; Riederer P
CNTF and endogenous psychoses?
Nature genetics 1996;12(2):123.
1996: Thome J; Kornhuber J; Baumer A; Rösler M; Beckmann H; Riederer P
Association between a null mutation in the human ciliary neurotrophic factor (CNTF) gene and increased incidence of psychiatric diseases?
Neuroscience letters 1996;203(2):109-10.
1996: Gerlach M; Götz M; Dirr A; Kupsch A; Janetzky B; Oertel W; Sautter J; Schwarz J; Reichmann H; Riederer P
Acute MPTP treatment produces no changes in mitochondrial complex activities and indices of oxidative damage in the common marmoset ex vivo one week after exposure to the toxin.
Neurochemistry international 1996;28(1):41-9.
1996: Retz W; Kornhuber J; Riederer P
Neurotransmission and the ontogeny of human brain.
Journal of neural transmission (Vienna, Austria : 1996) 1996;103(4):403-19.
1996: Kornhuber J; Schoppmeyer K; Bendig C; Riederer P
Characterization of [3H]pentazocine binding sites in post-mortem human frontal cortex.
Journal of neural transmission (Vienna, Austria : 1996) 1996;103(1-2):45-53.
1996: Naumann M; Götz M; Reiners K; Lange K W; Riederer P
Neurotransmitters in CSF of idiopathic adult-onset dystonia: reduced 5-HIAA levels as evidence of impaired serotonergic metabolism.
Journal of neural transmission (Vienna, Austria : 1996) 1996;103(8-9):1083-91.
1996: Mogi M; Harada M; Kondo T; Riederer P; Nagatsu T
Interleukin-2 but not basic fibroblast growth factor is elevated in parkinsonian brain. Short communication.
Journal of neural transmission (Vienna, Austria : 1996) 1996;103(8-9):1077-81.
1996: Gerlach M; Riederer P
Animal models of Parkinson's disease: an empirical comparison with the phenomenology of the disease in man.
Journal of neural transmission (Vienna, Austria : 1996) 1996;103(8-9):987-1041.
1996: Gerlach M; Desser H; Youdim M B; Riederer P
New horizons in molecular mechanisms underlying Parkinson's disease and in our understanding of the neuroprotective effects of selegiline.
Journal of neural transmission. Supplementum 1996;48():7-21.
1996: Gsell W; Strein I; Riederer P
The neurochemistry of Alzheimer type, vascular type and mixed type dementias compared.
Journal of neural transmission. Supplementum 1996;47():73-101.
1996: Przuntek H; Welzel D; Gerlach M; Blümner E; Danielczyk W; Kaiser H J; Kraus P H; Letzel H; Riederer P; Uberla K
Early institution of bromocriptine in Parkinson's disease inhibits the emergence of levodopa-associated motor side effects. Long-term results of the PRADO study.
Journal of neural transmission (Vienna, Austria : 1996) 1996;103(6):699-715.
1996: Thome J; Münch G; Müller R; Schinzel R; Kornhuber J; Blum-Degen D; Sitzmann L; Rösler M; Heidland A; Riederer P
Advanced glycation endproducts-associated parameters in the peripheral blood of patients with Alzheimer's disease.
Life sciences 1996;59(8):679-85.
1996: Staedt J; Stoppe G; Riemann H; Hajak G; Rüther E; Riederer P
Lamotrigine in the treatment of nocturnal myoclonus syndrome (NMS): two case reports.
Journal of neural transmission (Vienna, Austria : 1996) 1996;103(3):355-61.
1996: Janetzky B; Schmid C; Bischof F; Frölich L; Gsell W; Kalaria R N; Riederer P; Reichmann H
Investigations on the point mutations at nt 5460 of the mtDNA in different neurodegenerative and neuromuscular diseases.
European neurology 1996;36(3):149-53.
1996: Gerlach M; Riederer P; Youdim M B
Molecular mechanisms for neurodegeneration. Synergism between reactive oxygen species, calcium, and excitotoxic amino acids.
Advances in neurology 1996;69():177-94.
1995: Blum-Degen D; Müller T; Kuhn W; Gerlach M; Przuntek H; Riederer P
Interleukin-1 beta and interleukin-6 are elevated in the cerebrospinal fluid of Alzheimer's and de novo Parkinson's disease patients.
Neuroscience letters 1995;202(1-2):17-20.
1995: Fischer B; Schmoll H; Riederer P; Bauer J; Platt D; Popa-Wagner A
Complement C1q and C3 mRNA expression in the frontal cortex of Alzheimer's patients.
Journal of molecular medicine (Berlin, Germany) 1995;73(9):465-71.
1995: Gerlach M; Trautwein A X; Zecca L; Youdim M B; Riederer P
Mössbauer spectroscopic studies of purified human neuromelanin isolated from the substantia nigra.
Journal of neurochemistry 1995;65(2):923-6.
1995: Kornhuber J; Quack G; Danysz W; Jellinger K; Danielczyk W; Gsell W; Riederer P
Therapeutic brain concentration of the NMDA receptor antagonist amantadine.
Neuropharmacology 1995;34(7):713-21.
1995: Müller W E; Mutschler E; Riederer P
Noncompetitive NMDA receptor antagonists with fast open-channel blocking kinetics and strong voltage-dependency as potential therapeutic agents for Alzheimer's dementia.
Pharmacopsychiatry 1995;28(4):113-24.
1995: Gerlach M; Riederer P; Youdim M B
Neuroprotective therapeutic strategies. Comparison of experimental and clinical results.
Biochemical pharmacology 1995;50(1):1-16.
1995: Mogi M; Harada M; Kondo T; Narabayashi H; Riederer P; Nagatsu T
Transforming growth factor-beta 1 levels are elevated in the striatum and in ventricular cerebrospinal fluid in Parkinson's disease.
Neuroscience letters 1995;193(2):129-32.
1995: Gerlach M; Oehler D; Blum-Degen D; Lange K W; Mayer B; Reichmann H; Riederer P
Regional distribution and characterization of nitric oxide synthase activity in the brain of the common marmoset.
Neuroreport 1995;6(8):1141-5.
1995: Künig G; Hartmann J; Krause F; Deckert J; Heinsen H; Ransmayr G; Beckmann H; Riederer P
Regional differences in the interaction of the excitotoxins domoate and L-beta-oxalyl-amino-alanine with [3H]kainate binding sites in human hippocampus.
Neuroscience letters 1995;187(2):107-10.
1995: Frölich L; Riederer P
Free radical mechanisms in dementia of Alzheimer type and the potential for antioxidative treatment.
Arzneimittel-Forschung 1995;45(3A):443-6.
1995: Kupsch A; Gerlach M; Pupeter S C; Sautter J; Dirr A; Arnold G; Opitz W; Przuntek H; Riederer P; Oertel W H
Pretreatment with nimodipine prevents MPTP-induced neurotoxicity at the nigral, but not at the striatal level in mice.
Neuroreport 1995;6(4):621-5.
1995: Lesch K P; Gross J; Franzek E; Wolozin B L; Riederer P; Murphy D L
Primary structure of the serotonin transporter in unipolar depression and bipolar disorder.
Biological psychiatry 1995;37(4):215-23.
1995: Fritze J; Lanczik M; Sofic E; Struck M; Riederer P
Cholinergic neurotransmission seems not to be involved in depression but possibly in personality.
Journal of psychiatry & neuroscience : JPN 1995;20(1):39-48.
1995: Thome J; Baumer A; Kornhuber J; Rösler M; Riederer P
Alpha-1-antichymotrypsin bi-allele polymorphism, apolipoprotein-E tri-allele polymorphism and genetic risk of Alzheimer's syndrome.
Journal of neural transmission. Parkinson's disease and dementia section 1995;10(2-3):207-12.
1995: Kornhuber J; Retz W; Riederer P
Slow accumulation of psychotropic substances in the human brain. Relationship to therapeutic latency of neuroleptic and antidepressant drugs?
Journal of neural transmission. Supplementum 1995;46():315-23.
1995: Sontag K H; Heim C; Sontag T A; God R; Reichmann H; Wesemann W; Rausch W D; Riederer P; Bringmann G
Long-term behavioural effects of TaClo (1-trichloromethyl-1,2,3,4-tetrahydro-beta-carboline) after subchronic treatment in rats.
Journal of neural transmission. Supplementum 1995;46():283-9.
1995: Grote C; Clement H W; Wesemann W; Bringmann G; Feineis D; Riederer P; Sontag K H
Biochemical lesions of the nigrostriatal system by TaClo (1-trichloromethyl-1,2,3,4-tetrahydro-beta-carboline) and derivatives.
Journal of neural transmission. Supplementum 1995;46():275-81.
1995: Bringmann G; God R; Feineis D; Wesemann W; Riederer P; Rausch W D; Reichmann H; Sontag K H
The TaClo concept: 1-trichloromethyl-1,2,3,4-tetrahydro-beta-carboline (TaClo), a new toxin for dopaminergic neurons.
Journal of neural transmission. Supplementum 1995;46():235-44.
1995: Wesemann W; Solbach M; Nafe R; Grote C; Sontag K H; Riederer P; Jellinger K; Mennel H D; Clement H W
Effect of lazaroid U-74389G on iron-induced reduction of striatal dopamine metabolism.
Journal of neural transmission. Supplementum 1995;46():175-82.
1995: Reichmann H; Janetzky B; Riederer P
Iron-dependent enzymes in Parkinson's disease.
Journal of neural transmission. Supplementum 1995;46():157-64.
1995: Götz M E; Dirr A; Burger R; Rausch W D; Riederer P
High dose selegiline augments striatal ubiquinol in mouse: an indication of decreased oxidative stress or of interference with mitochondrial respiration? A pilot study.
Journal of neural transmission. Supplementum 1995;46():149-56.
1995: Blum-Degen D; Frölich L; Hoyer S; Riederer P
Altered regulation of brain glucose metabolism as a cause of neurodegenerative disorders?
Journal of neural transmission. Supplementum 1995;46():139-47.
1995: Kornhuber J; Herr B; Thome J; Riederer P
The antiparkinsonian drug budipine binds to NMDA and sigma receptors in postmortem human brain tissue.
Journal of neural transmission. Supplementum 1995;46():131-7.
1995: Riederer P; Gsell W; Calza L; Franzek E; Jungkunz G; Jellinger K; Reynolds G P; Crow T; Cruz-Sánchez F F; Beckmann H
Consensus on minimal criteria of clinical and neuropathological diagnosis of schizophrenia and affective disorders for post mortem research. Report from the European Dementia and Schizophrenia Network (BIOMED I).
Journal of neural transmission. General section 1995;102(3):255-64.
1995: Heils A; Teufel A; Petri S; Seemann M; Bengel D; Balling U; Riederer P; Lesch K P
Functional promoter and polyadenylation site mapping of the human serotonin (5-HT) transporter gene.
Journal of neural transmission. General section 1995;102(3):247-54.
1995: Kornhuber J; Parsons C G; Hartmann S; Retz W; Kamolz S; Thome J; Riederer P
Orphenadrine is an uncompetitive N-methyl-D-aspartate (NMDA) receptor antagonist: binding and patch clamp studies.
Journal of neural transmission. General section 1995;102(3):237-46.
1995: Gsell W; Reichert N; Youdim M B; Riederer P
Interaction of neuroprotective substances with human brain superoxide dismutase. An in vitro study.
Journal of neural transmission. Supplementum 1995;45():271-9.
1995: Mogi M; Harada M; Kondo T; Riederer P; Nagatsu T
Brain beta 2-microglobulin levels are elevated in the striatum in Parkinson's disease.
Journal of neural transmission. Parkinson's disease and dementia section 1995;9(1):87-92.
1995: Kolasiewicz W; Jaros T; Heim C; Melzacka M; Sieklucka M; Weiner N; Wesemann W; Riederer P; Sontag K H
Injection of a minuscule dose of FeCl3 within the ventrolateral striatum causes a chronic disturbance of the integrative function within the limbic part of the ventral striatum.
Journal of neural transmission. Parkinson's disease and dementia section 1995;9(1):15-29.
1994: Lange K W; Riederer P; Youdim M B
Biochemical actions of l-deprenyl (selegiline).
Clinical pharmacology and therapeutics 1994;56(6 Pt 2):734-41.
1994: Koutsilieri E; O'Callaghan J F; Chen T S; Riederer P; Rausch W D
Selegiline enhances survival and neurite outgrowth of MPP(+)-treated dopaminergic neurons.
European journal of pharmacology 1994;269(3):R3-4.
1994: Youdim M B; Lavie L; Riederer P
Oxygen free radicals and neurodegeneration in Parkinson's disease: a role for nitric oxide.
Annals of the New York Academy of Sciences 1994;738():64-8.
1994: Oestreicher E; Sengstock G J; Riederer P; Olanow C W; Dunn A J; Arendash G W
Degeneration of nigrostriatal dopaminergic neurons increases iron within the substantia nigra: a histochemical and neurochemical study.
Brain research 1994;660(1):8-18.
1994: Mogi M; Harada M; Kondo T; Riederer P; Inagaki H; Minami M; Nagatsu T
Interleukin-1 beta, interleukin-6, epidermal growth factor and transforming growth factor-alpha are elevated in the brain from parkinsonian patients.
Neuroscience letters 1994;180(2):147-50.
1994: Gerlach M; Ben-Shachar D; Riederer P; Youdim M B
Altered brain metabolism of iron as a cause of neurodegenerative diseases?
Journal of neurochemistry 1994;63(3):793-807.
1994: Ransmayr G; Benesch H; Nowakowski C; Künig G; Heinsen H; Riederer P; Hersh L B
Neurofibrillary tangles without cell loss in the lateral vestibular nucleus of patients with Alzheimer's disease.
Neuroscience letters 1994;177(1-2):11-4.
1994: Kornhuber J; Lange K W; Kruzik P; Rausch W D; Gabriel E; Jellinger K; Riederer P
Iron, copper, zinc, magnesium, and calcium in postmortem brain tissue from schizophrenic patients.
Biological psychiatry 1994;36(1):31-4.
1994: Berger W; Deckert J; Hartmann J; Krotzer C; Kornhuber J; Ransmayr G; Heinsen H; Beckmann H; Riederer P
Memantine inhibits [3H]MK-801 binding to human hippocampal NMDA receptors.
Neuroreport 1994;5(10):1237-40.
1994: Fischer P; Götz M E; Ellinger B; Streifler M; Riederer P; Danielczyk W
Platelet monoamine oxidase B activity and vitamin B12 in dementia.
Biological psychiatry 1994;35(10):772-4.
1994: Janetzky B; Hauck S; Youdim M B; Riederer P; Jellinger K; Pantucek F; Zöchling R; Boissl K W; Reichmann H
Unaltered aconitase activity, but decreased complex I activity in substantia nigra pars compacta of patients with Parkinson's disease.
Neuroscience letters 1994;169(1-2):126-8.
1994: Künig G; Hartmann J; Niedermeyer B; Deckert J; Ransmayr G; Heinsen H; Beckmann H; Riederer P
Excitotoxins L-beta-oxalyl-amino-alanine (L-BOAA) and 3,4,6-trihydroxyphenylalanine (6-OH-DOPA) inhibit [3H] alpha-amino-3- hydroxy-5-methyl-4-isoxazole-propionic acid (AMPA) binding in human hippocampus.
Neuroscience letters 1994;169(1-2):219-22.
1994: Götz M E; Dirr A; Burger R; Janetzky B; Weinmüller M; Chan W W; Chen S C; Reichmann H; Rausch W D; Riederer P
Effect of lipoic acid on redox state of coenzyme Q in mice treated with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and diethyldithiocarbamate.
European journal of pharmacology 1994;266(3):291-300.
1994: Mogi M; Harada M; Riederer P; Narabayashi H; Fujita K; Nagatsu T
Tumor necrosis factor-alpha (TNF-alpha) increases both in the brain and in the cerebrospinal fluid from parkinsonian patients.
Neuroscience letters 1994;165(1-2):208-10.
1994: Ozawa H; Saito T; Hatta S; Hashimoto E; Froelich L; Ohshika H; Takahata N; Riederer P
Reduced sensitivity to ethanol of Gs alpha and Gi/o alpha in the cerebral cortex of alcoholic patients.
Alcohol and alcoholism (Oxford, Oxfordshire). Supplement 1994;29(1):93-7.
1994: Saito T; Ozawa H; Katamura Y; Hatta S; Takahata N; Riederer P
Alterations of receptor-G protein-adenylyl cyclase coupling in alcoholics.
Alcohol and alcoholism (Oxford, Oxfordshire). Supplement 1994;2():211-5.
1994: Lange K W; Riederer P
Glutamatergic drugs in Parkinson's disease.
Life sciences 1994;55(25-26):2067-75.
1994: Götz M E; Künig G; Riederer P; Youdim M B
Oxidative stress: free radical production in neural degeneration.
Pharmacology & therapeutics 1994;63(1):37-122.
1994: Deckert J; Hennemann A; Bereznai B; Fritze J; Vock R; Marangos P J; Riederer P
(3H)dipyridamole and (3H)nitrobenzylthioinosine binding sites at the human parietal cortex and erythrocyte adenosine transporter: a comparison.
Life sciences 1994;55(21):1675-82.
1994: Gerlach M; Youdim M B; Riederer P
Is selegiline neuroprotective in Parkinson's disease?
Journal of neural transmission. Supplementum 1994;41():177-88.
1994: Ichinose H; Ohye T; Fujita K; Pantucek F; Lange K; Riederer P; Nagatsu T
Quantification of mRNA of tyrosine hydroxylase and aromatic L-amino acid decarboxylase in the substantia nigra in Parkinson's disease and schizophrenia.
Journal of neural transmission. Parkinson's disease and dementia section 1994;8(1-2):149-58.
1994: Kornhuber J; Weller M; Schoppmeyer K; Riederer P
Amantadine and memantine are NMDA receptor antagonists with neuroprotective properties.
Journal of neural transmission. Supplementum 1994;43():91-104.
1994: Hartmann J; Ransmayr G; Riederer P
The glycine binding site of the NMDA receptor: involvement in neurodegeneration and new approach for neuroprotection.
Journal of neural transmission. Supplementum 1994;43():53-7.
1994: Lange K W; Rausch W D; Gsell W; Naumann M; Oestreicher E; Riederer P
Neuroprotection by dopamine agonists.
Journal of neural transmission. Supplementum 1994;43():183-201.
1994: Götz M E; Dirr A; Gsell W; Burger R; Janetzky B; Freyberger A; Reichmann H; Rausch W D; Riederer P
Influence of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine, lipoic acid and L-deprenyl on the interplay between cellular redox systems.
Journal of neural transmission. Supplementum 1994;43():145-62.
1994: Youdim M B; Ben-Shachar D; Riederer P
The enigma of neuromelanin in Parkinson's disease substantia nigra.
Journal of neural transmission. Supplementum 1994;43():113-22.
1994: Lesch K P; Balling U; Gross J; Strauss K; Wolozin B L; Murphy D L; Riederer P
Organization of the human serotonin transporter gene.
Journal of neural transmission. General section 1994;95(2):157-62.
1994: Wesemann W; Blaschke S; Solbach M; Grote C; Clement H W; Riederer P
Intranigral injected iron progressively reduces striatal dopamine metabolism.
Journal of neural transmission. Parkinson's disease and dementia section 1994;8(3):209-14.
1994: Münch G; Taneli Y; Schraven E; Schindler U; Schinzel R; Palm D; Riederer P
The cognition-enhancing drug tenilsetam is an inhibitor of protein crosslinking by advanced glycosylation.
Journal of neural transmission. Parkinson's disease and dementia section 1994;8(3):193-208.
1994: Lesch K P; Stöber G; Balling U; Franzek E; Li S H; Ross C A; Newman M; Beckmann H; Riederer P
Triplet repeats in clinical subtypes of schizophrenia: variation at the DRPLA (B 37 CAG repeat) locus is not associated with periodic catatonia.
Journal of neural transmission. General section 1994;98(2):153-7.
1994: Lesch K P; Gross J; Wolozin B L; Franzek E; Bengel D; Riederer P; Murphy D L
Direct sequencing of the reserpine-sensitive vesicular monamine transporter complementary DNA in unipolar depression and manic depressive illness.
Psychiatric genetics 1994;4(3):153-60.
1994: Böckelmann R; Wolf G; Ransmayr G; Riederer P
NADPH-diaphorase/nitric oxide synthase containing neurons in normal and Parkinson's disease putamen.
Journal of neural transmission. Parkinson's disease and dementia section 1994;7(2):115-21.
1994: Künig G; Niedermeyer B; Krause F; Hartmann J; Deckert J; Ransmayr G; Heinsen H; Beckmann H; Riederer P
Interactions of neurotoxins with non-NMDA glutamate receptors: an autoradiographic study.
Journal of neural transmission. Supplementum 1994;43():59-62.
1993: Kornhuber J; Schoppmeyer K; Riederer P
Affinity of 1-aminoadamantanes for the sigma binding site in post-mortem human frontal cortex.
Neuroscience letters 1993;163(2):129-31.
1993: Lange K W; Löschmann P A; Sofic E; Burg M; Horowski R; Kalveram K T; Wachtel H; Riederer P
The competitive NMDA antagonist CPP protects substantia nigra neurons from MPTP-induced degeneration in primates.
Naunyn-Schmiedeberg's archives of pharmacology 1993;348(6):586-92.
1993: Frölich L; Dirr A; Riederer P; Hoyer S
Effects of long-term recovery from transient cerebral ischemia in rat brain: tissue levels of acetylcholine, monoamines, and their metabolites.
Neurochemical research 1993;18(12):1239-44.
1993: Ozawa H; Katamura Y; Hatta S; Saito T; Katada T; Gsell W; Froelich L; Takahata N; Riederer P
Alterations of guanine nucleotide-binding proteins in post-mortem human brain in alcoholics.
Brain research 1993;620(1):174-9.
1993: Deckert J; Bereznai B; Hennemann A; Gsell W; Götz M; Fritze J; Riederer P
Nimodipine inhibits [3H]nitrobenzylthioinosine binding to the adenosine transporter in human brain.
European journal of pharmacology 1993;238(1):131-3.
1993: Reichmann H; Flörke S; Hebenstreit G; Schrubar H; Riederer P
Analyses of energy metabolism and mitochondrial genome in post-mortem brain from patients with Alzheimer's disease.
Journal of neurology 1993;240(6):377-80.
1993: de Knegt R J; Kornhuber J; Schalm S W; Rusche K; Riederer P; Tan J
Binding of the ligand [3H]MK-801 to the MK-801 binding site of the N-methyl-D-aspartate receptor during experimental encephalopathy from acute liver failure and from acute hyperammonemia in the rabbit.
Metabolic brain disease 1993;8(2):81-94.
1993: Hashimoto E; Ozawa H; Saito T; Hatta S; Riederer P; Takahata N
GTP binding proteins in postmortem human brain.
The Japanese journal of psychiatry and neurology 1993;47(2):413.
1993: Jellinger K; Kienzl E; Rumpelmair G; Riederer P; Stachelberger H; Ben-Shachar D; Youdim M B
Neuromelanin and nigrostriatal dopamine neuron degeneration.
Journal of neurochemistry 1993;60(5):1976-7.
1993: Wodarz N; Fritze J; Riederer P; Beckmann H
3H-spiroperidol binding to peripheral mononuclear cells in schizophrenic and healthy subjects.
Biological psychiatry 1993;33(10):727-33.
1993: Reichmann H; Janetzky B; Klinge M; Riederer P
[Parkinson disease--a mitochondrial myopathy?]
Der Nervenarzt 1993;64(4):215-20.
1993: Ozawa H; Katamura Y; Hashimoto E; Hatta S; Saito T; Riederer P; Takahata N
[Effects of ethanol on GTP-binding protein function in human brain cortex]
Arukoru kenkyu to yakubutsu izon = Japanese journal of alcohol studies & drug dependence 1993;28(2):49-53.
1993: Kornhuber J; Riederer P
N-methyl-D-aspartate (NMDA) antagonists in Parkinson's disease.
Journal of neurology, neurosurgery, and psychiatry 1993;56(4):427.
1993: Gerlach M; Russ H; Winker J; Witzmann K; Traber J; Stasch J P; Riederer P; Przuntek H
Effects of nimodipine on the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced depletions in the biogenic amine levels in mice.
Arzneimittel-Forschung 1993;43(4):413-5.
1993: Götz M E; Dirr A; Freyberger A; Burger R; Riederer P
The thiobarbituric acid assay reflects susceptibility to oxygen induced lipid peroxidation in vitro rather than levels of lipid hydroperoxides in vivo: a methodological approach.
Neurochemistry international 1993;22(3):255-62.
1993: Deckert J; Berger W; Kleopa K; Heckers S; Ransmayr G; Heinsen H; Beckmann H; Riederer P
Adenosine A1 receptors in human hippocampus: inhibition of [3H]8-cyclopentyl-1,3-dipropylxanthine binding by antagonist drugs.
Neuroscience letters 1993;150(2):191-4.
1993: Lesch K P; Wolozin B L; Estler H C; Murphy D L; Riederer P
Isolation of a cDNA encoding the human brain serotonin transporter.
Journal of neural transmission. General section 1993;91(1):67-72.
1993: Jellinger K A; Kienzl E; Rumpelmaier G; Paulus W; Riederer P; Stachelberger H; Youdim M B; Ben-Shachar D
Iron and ferritin in substantia nigra in Parkinson's disease.
Advances in neurology 1993;60():267-72.
1993: Youdim M B; Ben-Shachar D; Riederer P
The possible role of iron in the etiopathology of Parkinson's disease.
Movement disorders : official journal of the Movement Disorder Society 1993;8(1):1-12.
1993: Youdim M B; Riederer P
Dopamine metabolism and neurotransmission in primate brain in relationship to monoamine oxidase A and B inhibition.
Journal of neural transmission. General section 1993;91(2-3):181-95.
1993: Reichmann H; Lestienne P; Jellinger K; Riederer P
Parkinson's disease and the electron transport chain in postmortem brain.
Advances in neurology 1993;60():297-9.
1993: Youdim M B; Ben-Shachar D; Eshel G; Finberg J P; Riederer P
The neurotoxicity of iron and nitric oxide. Relevance to the etiology of Parkinson's disease.
Advances in neurology 1993;60():259-66.
1993: Lesch K P; Gross J; Wolozin B L; Murphy D L; Riederer P
Extensive sequence divergence between the human and rat brain vesicular monoamine transporter: possible molecular basis for species differences in the susceptibility to MPP+.
Journal of neural transmission. General section 1993;93(1):75-82.
1993: Youdim M B; Riederer P
The relevance of glial monoamine oxidase-B and polyamines to the action of selegiline in Parkinson's disease.
Movement disorders : official journal of the Movement Disorder Society 1993;8 Suppl 1():S8-13.
1993: Youdim M B; Riederer P
The role of iron in senescence of dopaminergic neurons in Parkinson's disease.
Journal of neural transmission. Supplementum 1993;40():57-67.
1993: Ozawa H; Gsell W; Frölich L; Zöchling R; Pantucek F; Beckmann H; Riederer P
Imbalance of the Gs and Gi/o function in post-mortem human brain of depressed patients.
Journal of neural transmission. General section 1993;94(1):63-9.
1993: Kornhuber M E; Kornhuber J; Retz W; Riederer P
L-glutamate and L-aspartate concentrations in the developing and aging human putamen tissue.
Journal of neural transmission. General section 1993;93(2):145-50.
1993: Kornhuber J; Weller M; Riederer P
Glutamate receptor antagonists for neuroleptic malignant syndrome and akinetic hyperthermic parkinsonian crisis.
Journal of neural transmission. Parkinson's disease and dementia section 1993;6(1):63-72.
1993: Hartmann J; Künig G; Riederer P
Involvement of transmitter systems in neuropsychiatric diseases.
Acta neurologica Scandinavica. Supplementum 1993;146():18-21.
1993: Riederer P; Lange K W; Youdim M B
Recent advances in pharmacological therapy of Parkinson's disease.
Advances in neurology 1993;60():626-35.
1992: Riederer P; Laux G
Therapeutic drug monitoring of psychotropics: report of a consensus conference.
Pharmacopsychiatry 1992;25(6):271-2.
1992: Jellinger K; Kienzl E; Rumpelmair G; Riederer P; Stachelberger H; Ben-Shachar D; Youdim M B
Iron-melanin complex in substantia nigra of parkinsonian brains: an x-ray microanalysis.
Journal of neurochemistry 1992;59(3):1168-71.
1992: Sofic E; Lange K W; Jellinger K; Riederer P
Reduced and oxidized glutathione in the substantia nigra of patients with Parkinson's disease.
Neuroscience letters 1992;142(2):128-30.
1992: Gerlach M; Riederer P; Youdim M B
The molecular pharmacology of L-deprenyl.
European journal of pharmacology 1992;226(2):97-108.
1992: Riederer P; Lange K W
Pathogenesis of Parkinson's disease.
Current opinion in neurology and neurosurgery 1992;5(3):295-300.
1992: Konradi C; Kornhuber J; Sofic E; Heckers S; Riederer P; Beckmann H
Variations of monoamines and their metabolites in the human brain putamen.
Brain research 1992;579(2):285-90.
1992: Wodarz N; Rupprecht R; Kornhuber J; Schmitz B; Wild K; Riederer P
Cell-mediated immunity and its glucocorticoid-sensitivity after clinical recovery from severe major depressive disorder.
Journal of affective disorders 1992;25(1):31-8.
1992: Wodarz N; Fritze J; Kornhuber J; Riederer P
3H-spiroperidol binding to human peripheral mononuclear cells: methodological aspects.
Biological psychiatry 1992;31(3):291-303.
1992: Riederer P; Lange K W; Kornhuber J; Danielczyk W
Glutamatergic-dopaminergic balance in the brain. Its importance in motor disorders and schizophrenia.
Arzneimittel-Forschung 1992;42(2A):265-8.
1992: Ben-Shachar D; Eshel G; Riederer P; Youdim M B
Role of iron and iron chelation in dopaminergic-induced neurodegeneration: implication for Parkinson's disease.
Annals of neurology 1992;32 Suppl():S105-10.
1992: Riederer P; Dirr A; Goetz M; Sofic E; Jellinger K; Youdim M B
Distribution of iron in different brain regions and subcellular compartments in Parkinson's disease.
Annals of neurology 1992;32 Suppl():S101-4.
1992: Lange K W; Youdim M B; Riederer P
Neurotoxicity and neuroprotection in Parkinson's disease.
Journal of neural transmission. Supplementum 1992;38():27-44.
1992: Przuntek H; Welzel D; Blümner E; Danielczyk W; Letzel H; Kaiser H J; Kraus P H; Riederer P; Schwarzmann D; Wolf H
Bromocriptine lessens the incidence of mortality in L-dopa-treated parkinsonian patients: prado-study discontinued.
European journal of clinical pharmacology 1992;43(4):357-63.
1991: Gerlach M; Riederer P; Przuntek H; Youdim M B
MPTP mechanisms of neurotoxicity and their implications for Parkinson's disease.
European journal of pharmacology 1991;208(4):273-86.
1991: Ben-Shachar D; Riederer P; Youdim M B
Iron-melanin interaction and lipid peroxidation: implications for Parkinson's disease.
Journal of neurochemistry 1991;57(5):1609-14.
1991: Riederer P; Lange K W; Kornhuber J; Danielczyk W
Pharmacotoxic psychosis after memantine in Parkinson's disease.
Lancet 1991;338(8773):1022-3.
1991: Wodarz N; Rupprecht R; Kornhuber J; Schmitz B; Wild K; Braner H U; Riederer P
Normal lymphocyte responsiveness to lectins but impaired sensitivity to in vitro glucocorticoids in major depression.
Journal of affective disorders 1991;22(4):241-8.
1991: Rupprecht R; Kornhuber J; Wodarz N; Lugauer J; Göbel C; Haack D; Beck G; Müller O A; Riederer P; Beckmann H
Disturbed glucocorticoid receptor autoregulation and corticotropin response to dexamethasone in depressives pretreated with metyrapone.
Biological psychiatry 1991;29(11):1099-109.
1991: Lestienne P; Nelson I; Riederer P; Reichmann H; Jellinger K
Mitochondrial DNA in postmortem brain from patients with Parkinson's disease.
Journal of neurochemistry 1991;56(5):1819.
1991: Rupprecht R; Kornhuber J; Wodarz N; Lugauer J; Göbel C; Riederer P; Beckmann H
Lymphocyte glucocorticoid receptor binding during depression and after clinical recovery.
Journal of affective disorders 1991;22(1-2):31-5.
1991: Kornhuber J; Bormann J; Hübers M; Rusche K; Riederer P
Effects of the 1-amino-adamantanes at the MK-801-binding site of the NMDA-receptor-gated ion channel: a human postmortem brain study.
European journal of pharmacology 1991;206(4):297-300.
1991: Sofic E; Paulus W; Jellinger K; Riederer P; Youdim M B
Selective increase of iron in substantia nigra zona compacta of parkinsonian brains.
Journal of neurochemistry 1991;56(3):978-82.
1991: Russ H; Mihatsch W; Gerlach M; Riederer P; Przuntek H
Neurochemical and behavioural features induced by chronic low dose treatment with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in the common marmoset: implications for Parkinson's disease?
Neuroscience letters 1991;123(1):115-8.
1991: Rupprecht M; Rupprecht R; Wodarz N; Braner H U; Kornhuber J; Koch H U; Riederer P; Hornstein O P
In vivo and in vitro effects of glucocorticoids on lectin-induced blastogenesis in atopic dermatitis.
Archives of dermatological research 1991;283(5):292-6.
1991: Mihatsch W; Russ H; Gerlach M; Riederer P; Przuntek H
Treatment with antioxidants does not prevent loss of dopamine in the striatum of MPTP-treated common marmosets: preliminary observations.
Journal of neural transmission. Parkinson's disease and dementia section 1991;3(1):73-8.
1991: Frölich L; Kornhuber J; Ihl R; Fritze J; Maurer K; Riederer P
Integrity of the blood-CSF barrier in dementia of Alzheimer type: CSF/serum ratios of albumin and IgG.
European archives of psychiatry and clinical neuroscience 1991;240(6):363-6.
1991: Sofic E; Riederer P; Wesemann W; Kienzl E; Eichinger K; Gsell W; Jellinger K
A study of brain dopamine sulfate levels in relation to free dopamine and homovanillic acid in Parkinson's disease.
Journal of neural transmission. Parkinson's disease and dementia section 1991;3(4):265-71.
1991: Sofic E; Riederer P; Gsell W; Gavranovic M; Schmidtke A; Jellinger K
Biogenic amines and metabolites in spinal cord of patients with Parkinson's disease and amyotrophic lateral sclerosis.
Journal of neural transmission. Parkinson's disease and dementia section 1991;3(2):133-42.
1991: Riederer P; Lange K W; Kornhuber J; Jellinger K
Glutamate receptor antagonism: neurotoxicity, anti-akinetic effects, and psychosis.
Journal of neural transmission. Supplementum 1991;34():203-10.
1991: Rupprecht M; Rupprecht R; Kornhuber J; Wodarz N; Koch H U; Riederer P; Hornstein O P
Elevated glucocorticoid receptor concentrations before and after glucocorticoid therapy in peripheral mononuclear leukocytes of patients with atopic dermatitis.
Dermatologica 1991;183(2):100-5.
1991: Rupprecht R; Wodarz N; Kornhuber J; Wild K; Schmitz B; Braner H U; Müller O A; Riederer P; Beckmann H
In vivo and in vitro effects of glucocorticoids on lymphocyte proliferation in depression.
European archives of psychiatry and clinical neuroscience 1991;241(1):35-40.
1991: Youdim M B; Ben-Shachar D; Riederer P
Iron in brain function and dysfunction with emphasis on Parkinson's disease.
European neurology 1991;31 Suppl 1():34-40.
1990: Rupprecht R; Kornhuber J; Wodarz N; Göbel C; Lugauer J; Sinzger C; Beckmann H; Riederer P; Möller O A
Characterization of Glucocorticoid Binding Capacity in Human Mononuclear Lymphocytes: Increase by Metyrapone is Prevented by Dexamethasone Pretreatment.
Journal of neuroendocrinology 1990;2(6):803-6.
1990: Fritze J; Sofic E; Müller T; Pfüller H; Lanczik M; Riederer P
Cholinergic-adrenergic balance: Part 2. Relationship between drug sensitivity and personality.
Psychiatry research 1990;34(3):271-9.
1990: Fritze J; Sofic E; Müller T; Pfüller H; Lanczik M; Riederer P
Cholinergic-adrenergic balance: Part 1. Relationship between central and peripheral sensitivities.
Psychiatry research 1990;34(3):259-70.
1990: Rupprecht R; Frölich L; Mergenthaler T; Kornhuber J; Wodarz N; Riederer P; Maurer K
Glucocorticoid receptors on mononuclear leukocytes in Alzheimer's disease.
Psychiatry research 1990;34(3):237-41.
1990: Lestienne P; Nelson J; Riederer P; Jellinger K; Reichmann H
Normal mitochondrial genome in brain from patients with Parkinson's disease and complex I defect.
Journal of neurochemistry 1990;55(5):1810-2.
1990: Schalling M; Friberg K; Seroogy K; Riederer P; Bird E; Schiffmann S N; Mailleux P; Vanderhaeghen J J; Kuga S; Goldstein M
Analysis of expression of cholecystokinin in dopamine cells in the ventral mesencephalon of several species and in humans with schizophrenia.
Proceedings of the National Academy of Sciences of the United States of America 1990;87(21):8427-31.
1990: Fritze J; Sofic E; Pfüller H; Lanczik M; Riederer P
Adrenergic-cholinergic imbalances: the physostigmine-syndrome is not antagonized by the MAO-A inhibitor brofaromine.
European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 1990;1(1):21-5.
1990: Fritze J; Becker T; Ziegler V; Laux G; Riederer P
Brofaromine (CGP 11 305 A) in treatment of depression: biological estimation of plasma concentrations.
Pharmacopsychiatry 1990;23(3):131-4.
1990: Frölich L; Strauss M; Kornhuber J; Hoyer S; Sorbi S; Riederer P; Amaducci L
Changes in pyruvate dehydrogenase complex (PDHc) activity and [3H]QNB-receptor binding in rat brain subsequent to intracerebroventricular injection of bromopyruvate.
Journal of neural transmission. Parkinson's disease and dementia section 1990;2(3):169-78.
1990: Riederer P; Carlsson A
Walther Birkmayer--a tribute on his 80th birthday.
Journal of neural transmission. General section 1990;81(2):I-IV.
1990: Götz M E; Freyberger A; Riederer P
Oxidative stress: a role in the pathogenesis of Parkinson's disease.
Journal of neural transmission. Supplementum 1990;29():241-9.
1990: Riederer P; Carlsson A
Walther Birkmayer--a tribute on his 80th birthday.
Journal of neural transmission. Parkinson's disease and dementia section 1990;2(1):I-IV.
1990: Riederer P; Konradi C; Youdim M B
The role of MAO in dopaminergic transmission.
Advances in neurology 1990;53():149-53.
1990: Oxenkrug G F; Anderson G F; Dragovic L; Blaivas M; Riederer P
Circadian rhythms of human pineal melatonin, related indoles, and beta adrenoreceptors: post-mortem evaluation.
Journal of pineal research 1990;9(1):1-11.
1990: Moll G; Moll R; Riederer P; Gsell W; Heinsen H; Denney R M
Immunofluorescence cytochemistry on thin frozen sections of human substantia nigra for staining of monoamine oxidase A and monoamine oxidase B: a pilot study.
Journal of neural transmission. Supplementum 1990;32():67-77.
1990: Kienzl E; Eichinger K; Sofic E; Jellinger K; Riederer P; Kuhn W; Fuchs G; Laux G
Urinary dopamine sulfate: regulations and significance in neurological disorders.
Journal of neural transmission. Supplementum 1990;32():471-9.
1990: Sofic E; Götz M; Frölich L; Burger R; Heckers S; Riederer P; Jellinger K; Beckmann H
Reflection of changes in membrane constituents in various regions of Alzheimer brains to differential scanning thermograms.
Journal of neural transmission. Supplementum 1990;32():259-67.
1990: Youdim M B; Ben-Shachar D; Riederer P
The role of monoamine oxidase, iron-melanin interaction, and intracellular calcium in Parkinson's disease.
Journal of neural transmission. Supplementum 1990;32():239-48.
1990: Fritze J; Becker T; Ziegler V; Laux G; Bieck P; Sofic E; Riederer P
Brofaromine (CGP 11 305 A): estimation of plasma concentrations by a biologic technique as compared to liquid chromatography.
Journal of neural transmission. Supplementum 1990;32():197-201.
1990: Laux G; Classen W; Sofic E; Becker T; Riederer P; Lesch K P; Struck M; Beckmann H
Clinical, biochemical and psychometric findings with the new MAO-A-inhibitors moclobemide and brofaromine in patients with major depressive disorder.
Journal of neural transmission. Supplementum 1990;32():189-95.
1990: Jellinger K; Paulus W; Grundke-Iqbal I; Riederer P; Youdim M B
Brain iron and ferritin in Parkinson's and Alzheimer's diseases.
Journal of neural transmission. Parkinson's disease and dementia section 1990;2(4):327-40.
1990: Youdim M B; Ben-Shachar D; Yehuda S; Riederer P
The role of iron in the basal ganglion.
Advances in neurology 1990;53():155-62.
1990: Rupprecht R; Wodarz N; Kornhuber J; Schmitz B; Wild K; Braner H U; Müller O A; Riederer P
In vivo and in vitro effects of glucocorticoids on lymphocyte proliferation in man: relationship to glucocorticoid receptors.
Neuropsychobiology 1990;24(2):61-6.
1990: Rausch W D; Schallauer E; Chan W W; Riederer P; Weiser M
Effects of L-deprenyl and amantadine in an MPTP-model of parkinsonism.
Journal of neural transmission. Supplementum 1990;32():269-75.
1989: Kornhuber J; Konradi C; Mack-Burkhardt F; Riederer P; Heinsen H; Beckmann H
Ontogenesis of monoamine oxidase-A and -B in the human brain frontal cortex.
Brain research 1989;499(1):81-6.
1989: Maurer K; Riederer P; Heinsen H; Beckmann H
Altered P300 topography due to functional and structural disturbances in the limbic system in dementia and psychoses and to pharmacological conditions.
Psychiatry research 1989;29(3):391-3.
1989: Rupprecht R; Rupprecht M; Rupprecht C; Sofic E; Barocka A; Beck G; Noder M; Riederer P
Effects of glucocorticoids on plasma catecholamines in depression.
Psychiatry research 1989;29(2):187-98.
1989: Riederer P; Konradi C; Hebenstreit G
[Neurochemical perspectives of the function of monoamine oxidases]
Psychiatrische Praxis 1989;16 Suppl 1():7-10.
1989: Kornhuber J; Bormann J; Retz W; Hübers M; Riederer P
Memantine displaces [3H]MK-801 at therapeutic concentrations in postmortem human frontal cortex.
European journal of pharmacology 1989;166(3):589-90.
1989: Kornhuber J; Mack-Burkhardt F; Riederer P
Regional distribution of [3H]MK-801 binding sites in the human brain.
Brain research 1989;489(2):397-9.
1989: Fritze J; Koronakis P; Konradi C; Riederer P
Isoelectric focusing of monoamine oxidase subtypes as identified by MAO inhibitors.
European journal of pharmacology 1989;172(2):147-54.
1989: Kornhuber J; Mack-Burkhardt F; Kornhuber M E; Riederer P
[3H]MK-801 binding sites in post-mortem human frontal cortex.
European journal of pharmacology 1989;162(3):483-90.
1989: Wolf-Dieter R; Heuschneider G; Sperk G; Riederer P
Biochemical events in spontaneous seizures in the Mongolian gerbil.
Metabolic brain disease 1989;4(1):3-7.
1989: Riederer P; Sofic E; Rausch W D; Schmidt B; Reynolds G P; Jellinger K; Youdim M B
Transition metals, ferritin, glutathione, and ascorbic acid in parkinsonian brains.
Journal of neurochemistry 1989;52(2):515-20.
1989: Kornhuber J; Mack-Burkhardt F; Konradi C; Fritze J; Riederer P
Effect of antemortem and postmortem factors on [3H]MK-801 binding in the human brain: transient elevation during early childhood.
Life sciences 1989;45(8):745-9.
1989: Konradi C; Kornhuber J; Froelich L; Fritze J; Heinsen H; Beckmann H; Schulz E; Riederer P
Demonstration of monoamine oxidase-A and -B in the human brainstem by a histochemical technique.
Neuroscience 1989;33(2):383-400.
1989: Youdim M B; Ben-Shachar D; Riederer P
Is Parkinson's disease a progressive siderosis of substantia nigra resulting in iron and melanin induced neurodegeneration?
Acta neurologica Scandinavica. Supplementum 1989;126():47-54.
1989: Riederer P; Konradi C; Hebenstreit G; Youdim M B
Neurochemical perspectives to the function of monoamine oxidase.
Acta neurologica Scandinavica. Supplementum 1989;126():41-5.
1989: Kornhuber J; Riederer P; Reynolds G P; Beckmann H; Jellinger K; Gabriel E
3H-spiperone binding sites in post-mortem brains from schizophrenic patients: relationship to neuroleptic drug treatment, abnormal movements, and positive symptoms.
Journal of neural transmission 1989;75(1):1-10.
1989: Kornhuber J; Mack-Burkhardt F; Riederer P; Hebenstreit G F; Reynolds G P; Andrews H B; Beckmann H
[3H]MK-801 binding sites in postmortem brain regions of schizophrenic patients.
Journal of neural transmission 1989;77(2-3):231-6.
1989: Sofic E; Halket J; Przyborowska A; Riederer P; Beckmann H; Sandler M; Jellinger K
Brain quinolinic acid in Alzheimer's dementia.
European archives of psychiatry and neurological sciences 1989;239(3):177-9.
1989: Fritze J; Laux G; Sofic E; Koronakis P; Schoerlin M P; Riederer P; Beckmann H
Plasma moclobemide and metabolites: lack of correlation with clinical response and biogenic amines.
Psychopharmacology 1989;99(2):252-6.
1988: Danielczyk W; Streifler M; Konradi C; Riederer P; Moll G
Platelet MAO-B activity and the psychopathology of Parkinson's disease, senile dementia and multi-infarct dementia.
Acta psychiatrica Scandinavica 1988;78(6):730-6.
1988: Youdim M B; Riederer P
Monoamine oxidase B; a misunderstood and misjudged enzyme.
Pharmacological research communications 1988;20 Suppl 4():9-14.
1988: Fritze J; Koronakis P; Riederer P; Hekman M
Lymphocyte adenylate cyclase: a model for putative adrenergic-cholinergic imbalances in affective disorders?
Pharmacopsychiatry 1988;21(6):436-7.
1988: Laux G; Becker T; Kühne G; Lesch K P; Riederer P; Beckmann H
Clinical and biochemical effects of the selective phosphodiesterase inhibitor rolipram in depressed inpatients controlled by determination of plasma level.
Pharmacopsychiatry 1988;21(6):378-9.
1988: Riederer P; Laux G; Beckmann H; Saletu B; Waldmeier P; Fritze J; DaPrada M; Möller H J; Schmauss M; Przuntek H
The new generation of selective monoamine oxidase-inhibitors: biochemical, pharmacological and clinical perspectives.
Pharmacopsychiatry 1988;21(6):283-4.
1988: Kornhuber J; Retz W; Riederer P; Heinsen H; Fritze J
Effect of antemortem and postmortem factors on [3H]glutamate binding in the human brain.
Neuroscience letters 1988;93(2-3):312-7.
1988: Riederer P; Sofic E; Heuschneider G; Benedetti M S; Dostert P
Secondary (toxic) parkinsonism as model of Parkinson's disease.
Functional neurology 1988;3(4):449-57.
1988: Becker T; Laux G; Sofic E; Riederer P; Beckmann H
[Schizophrenic psychosis in a patient with Gilles de la Tourette syndrome]
Der Nervenarzt 1988;59(10):616-20.
1988: Fritze J; Koronakis P; Riederer P
Erythrocyte membrane proteins in psychiatric disorders and controls.
Journal of affective disorders 1988;15(2):187-90.
1988: Konradi C; Svoma E; Jellinger K; Riederer P; Denney R; Thibault J
Topographic immunocytochemical mapping of monoamine oxidase-A, monoamine oxidase-B and tyrosine hydroxylase in human post mortem brain stem.
Neuroscience 1988;26(3):791-802.
1988: Fritze J; Sofic E; Riederer P; Beckmann H
Endocrine parameters and biogenic amines in relationship to psychopathology after cholinergic drug challenge (RS-86).
Psychiatry research 1988;25(3):339-48.
1988: Ferenci P; Riederer P; Jellinger K; Schafer D F; Jones E A
Changes in cerebral receptors for gamma aminobutyric acid in patients with hepatic encephalopathy.
Liver 1988;8(4):225-30.
1988: Riederer P; Rausch W D; Schmidt B; Kruzik P; Konradi C; Sofic E; Danielczyk W; Fischer M; Ogris E
Biochemical fundamentals of Parkinson's disease.
The Mount Sinai journal of medicine, New York 1988;55(1):21-8.
1988: Rausch W D; Hirata Y; Nagatsu T; Riederer P; Jellinger K
Tyrosine hydroxylase activity in caudate nucleus from Parkinson's disease: effects of iron and phosphorylating agents.
Journal of neurochemistry 1988;50(1):202-8.
1988: Sofic E; Riederer P; Heinsen H; Beckmann H; Reynolds G P; Hebenstreit G; Youdim M B
Increased iron (III) and total iron content in post mortem substantia nigra of parkinsonian brain.
Journal of neural transmission 1988;74(3):199-205.
1988: Riederer P
Factors contributing to fluctuations of the dopaminergic nigro-striatal feedback system in Parkinson's disease.
Journal of neural transmission. Supplementum 1988;27():191-9.
1988: Mogi M; Harada M; Kiuchi K; Kojima K; Kondo T; Narabayashi H; Rausch D; Riederer P; Jellinger K; Nagatsu T
Homospecific activity (activity per enzyme protein) of tyrosine hydroxylase increases in parkinsonian brain.
Journal of neural transmission 1988;72(1):77-82.
1987: Seeman P; Bzowej N H; Guan H C; Bergeron C; Reynolds G P; Bird E D; Riederer P; Jellinger K; Tourtellotte W W
Human brain D1 and D2 dopamine receptors in schizophrenia, Alzheimer's, Parkinson's, and Huntington's diseases.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 1987;1(1):5-15.
1987: Rausch W D; Schnecker K; Bruck J; Riederer P
[Changes in organic acids in plasma and cerebrospinal fluid in cerebral infarct]
Infusionstherapie und klinische Ernährung 1987;14(5):209-13.
1987: Schnecker K; Rausch W D; Bruck J; Riederer P
[Metabolic changes in ischemic brain infarct]
Wiener klinische Wochenschrift 1987;99(16):572-7.
1987: Brücke T; Danielczyk W; Simányi M; Sofic E; Riederer P
Terguride: partial dopamine agonist in the treatment of Parkinson's disease.
Advances in neurology 1987;45():573-6.
1987: Konradi C; Jellinger K; Riederer P; Nagatsu T
Histochemistry of MAO-A and MAO-B in the locus coeruleus of the Mongolian gerbil.
Journal of neural transmission 1987;70(3-4):369-76.
1987: Brücke T; Sofic E; Killian W; Rett A; Riederer P
Reduced concentrations and increased metabolism of biogenic amines in a single case of Rett-syndrome: a postmortem brain study.
Journal of neural transmission 1987;68(3-4):315-24.
1987: Seeman P; Bzowej N H; Guan H C; Bergeron C; Becker L E; Reynolds G P; Bird E D; Riederer P; Jellinger K; Watanabe S
Human brain dopamine receptors in children and aging adults.
Synapse (New York, N.Y.) 1987;1(5):399-404.
1987: Konradi C; Riederer P; Jellinger K; Denney R
Cellular action of MAO inhibitors.
Journal of neural transmission. Supplementum 1987;25():15-25.
1987: Sofic E; Riederer P; Killian W; Rett A
Reduced concentrations of ascorbic acid and glutathione in a single case of Rett syndrome: a postmortem brain study.
Brain & development 1987;9(5):529-31.
1987: Killian W; Riederer P; Linkesch W
Serum iron status in Rett syndrome.
Brain & development 1987;9(5):523-4.
1987: Riederer P; Konradi C; Schay V; Kienzl E; Birkmayer G; Danielczyk W; Sofic E; Youdim M B
Localization of MAO-A and MAO-B in human brain: a step in understanding the therapeutic action of L-deprenyl.
Advances in neurology 1987;45():111-8.
1987: Sperk G; Reynolds G P; Riederer P
HPLC analysis of somatostatin related peptides in putamen of Huntington's disease patients.
Journal of neural transmission 1987;69(1-2):153-60.
1987: Kruzik P; Sofic E; Riederer P; Gabriel E
Biochemical aspects of dysphoria: case study for hypothesis generation.
Psychopathology 1987;20(2):120-7.
1987: Riederer P; Kruzik P
Biochemical and morphological changes in the aging brain.
Electroencephalography and clinical neurophysiology. Supplement 1987;39():389-95.
1986: Brücke T; Riederer P
[Neurobiologic and pharmacologic studies on the pathogenesis of Parkinson disease]
Wiener medizinische Wochenschrift (1946) 1986;136(15-16):401-8.
1986: Guttman M; Seeman P; Reynolds G P; Riederer P; Jellinger K; Tourtellotte W W
Dopamine D2 receptor density remains constant in treated Parkinson's disease.
Annals of neurology 1986;19(5):487-92.
1986: Riederer P; Youdim M B
Monoamine oxidase activity and monoamine metabolism in brains of parkinsonian patients treated with l-deprenyl.
Journal of neurochemistry 1986;46(5):1359-65.
1986: Konradi C; Riederer P; Youdim M B
Hydrogen peroxide enhances the activity of monoamine oxidase type-B but not of type-A: a pilot study.
Journal of neural transmission. Supplementum 1986;22():61-73.
1986: Riederer P; Weiser M; Wichart I; Schmidt B; Killian W; Rett A
Preliminary brain autopsy findings in progredient Rett syndrome.
American journal of medical genetics. Supplement 1986;1():305-15.
1986: Birkmayer W; Riederer P
Biological aspects of depression in Parkinson's disease.
Psychopathology 1986;19 Suppl 2():58-61.
1985: Sieghart W; Eichinger A; Riederer P; Jellinger K
Comparison of benzodiazepine receptor binding in membranes from human or rat brain.
Neuropharmacology 1985;24(8):751-9.
1985: Kienzl E; Riederer P; Brücke T; Kleinberger G; Jellinger K
[Changes in and modulation of receptor activity in hepatic encephalopathy]
Infusionstherapie und klinische Ernährung 1985;12(1):32, 37-45.
1985: Riederer P; Beckmann H; Brücke T
[Current biochemical hypotheses of endogenous depression]
Wiener klinische Wochenschrift 1985;97(4):190-6.
1985: Jørgensen O S; Riederer P
Increased synaptic markers in hippocampus of depressed patients.
Journal of neural transmission 1985;64(1):55-66.
1985: Birkmayer W; Knoll J; Riederer P; Youdim M B; Hars V; Marton J
Increased life expectancy resulting from addition of L-deprenyl to Madopar treatment in Parkinson's disease: a longterm study.
Journal of neural transmission 1985;64(2):113-27.
1985: Riederer P; Brücke T; Sofic E; Kienzl E; Schnecker K; Schay V; Kruzik P; Killian W; Rett A
Neurochemical aspects of the Rett syndrome.
Brain & development 1985;7(3):351-60.
1984: Seeman P; Ulpian C; Bergeron C; Riederer P; Jellinger K; Gabriel E; Reynolds G P; Tourtellotte W W
Bimodal distribution of dopamine receptor densities in brains of schizophrenics.
Science (New York, N.Y.) 1984;225(4663):728-31.
1984: Jellinger K; Riederer P
Dementia in Parkinson's disease and (pre) senile dementia of Alzheimer type: morphological aspects and changes in the intracerebral MAO activity.
Advances in neurology 1984;40():199-210.
1984: Birkmayer W; Riederer P; Linauer W; Knoll J
L-deprenyl plus L-phenylalanine in the treatment of depression.
Journal of neural transmission 1984;59(1):81-7.
1984: Birkmayer W; Riederer P
Deprenyl prolongs the therapeutic efficacy of combined L-DOPA in Parkinson's disease.
Advances in neurology 1984;40():475-81.
1983: Gattaz W F; Riederer P; Reynolds G P; Gattaz D; Beckmann H
Dopamine and noradrenalin in the cerebrospinal fluid of schizophrenic patients.
Psychiatry research 1983;8(4):243-50.
1983: Jellinger K; Riederer P
[Central neurotransmitters in cerebral ischemia and stroke]
Fortschritte der Neurologie-Psychiatrie 1983;51(3):91-123.
1983: Riederer P; Reynolds G P; Jellinger K; Seemann D; Danielczyk W
Tranylcypromine isomers in Parkinson's disease. Effect of low doses on monoamine oxidase inhibition and blood pressure response.
Modern problems of pharmacopsychiatry 1983;19():154-61.
1983: Birkmayer W; Danielczyk W; Riederer P
Symptoms and side effects in the course of Parkinson's disease.
Journal of neural transmission. Supplementum 1983;19():185-99.
1983: Riederer P; Kienzl E; Jellinger K; Noller H; Kleinberger G
General properties of 14C-L-Valine-binding to human brain tissue.
Journal of neural transmission. Supplementum 1983;18():295-306.
1983: Birkmayer W; Birkmayer G; Lechner H; Riederer P
DL-3,4-threo-DOPS in Parkinson's disease: effects on orthostatic hypotension and dizziness.
Journal of neural transmission 1983;58(3-4):305-13.
1983: Reynolds G P; Riederer P
Assessment of MAO inhibitors using postmortem human brain tissue: biochemical and therapeutic implications.
Modern problems of pharmacopsychiatry 1983;19():255-9.
1983: Birkmayer W; Knoll J; Riederer P; Youdim M B
(-)-Deprenyl leads to prolongation of L-dopa efficacy in Parkinson's disease.
Modern problems of pharmacopsychiatry 1983;19():170-6.
1983: Riederer P; Jellinger K; Danielczyk W; Seemann D; Ulm G; Reynolds G P; Birkmayer W; Koppel H
Combination treatment with selective monoamine oxidase inhibitors and dopaminergic agonists in Parkinson's disease: biochemical and clinical observations.
Advances in neurology 1983;37():159-76.
1983: Noller H; Kienzl E; Riederer P
Coordination chemical aspects of receptor biochemistry.
Journal of neural transmission. Supplementum 1983;18():45-54.
1983: Riederer P; Jellinger K
Neurochemical insights into monoamine oxidase inhibitors, with special reference to deprenyl (selegiline).
Acta neurologica Scandinavica. Supplementum 1983;95():43-55.
1983: Rausch W D; Rossmanith W; Gruber J; Riederer P; Jellinger K; Weiser M
Studies on the neurotransmitter binding to pig brain microvessels.
Journal of neural transmission. Supplementum 1983;18():33-44.
1983: Beckmann H; Reynolds G P; Sandler M; Waldmeier P; Lauber J; Riederer P; Gattaz W F
Phenylethylamine and phenylacetic acid in CSF of schizophrenics and healthy controls.
Archiv für Psychiatrie und Nervenkrankheiten 1983;232(6):463-71.
1982: Kienzl E; Riederer P; Jellinger K; Kleinberger G
[Antagonism of the ammonia effect on serotonin receptors by L-valine]
Leber, Magen, Darm 1982;12(5):179-81.
1982: Riederer P; Toifl K; Kruzik P
Excretion of biogenic amine metabolites in anorexia nervosa.
Clinica chimica acta; international journal of clinical chemistry 1982;123(1-2):27-32.
1982: Riederer P; Jellinger K
Morphological and biochemical changes in the aging brain: pathophysiological and possible therapeutic consequences.
Experimental brain research. Experimentelle Hirnforschung. Expérimentation cérébrale 1982;Suppl 5():158-66.
1982: Jørgensen O S; Reynolds G P; Riederer P; Jellinger K
Parkinson's disease putamen: normal concentration of synaptic membrane marker antigens.
Journal of neural transmission 1982;54(3-4):171-9.
1982: Birkmayer W; Riederer P; Youdim M B
(-)Deprenyl in the treatment of Parkinson's disease.
Clinical neuropharmacology 1982;5(2):195-230.
1981: Reynolds G P; Riederer P; Jellinger K; Gabriel E
Dopamine receptors and schizophrenia: the neuroleptic drug problem.
Neuropharmacology 1981;20(12B):1319-20.
1981: Reynolds G P; Riederer P; Sandler M
Tranylcypromine isomers and Parkinson's disease: new aspects of an old drug.
Journal of the Royal Society of Medicine 1981;74(9):649-52.
1981: Riederer P; Reynolds G P
Determination of a wide range of urinary amine metabolites using a simple high-performance liquid chromatographic technique.
Journal of chromatography 1981;225(1):179-84.
1981: Vollmer R; Toifl K; Kothbauer P; Riederer P
[EEG- and biochemical findings in Kleine-Levin-syndrome. A case report (author's transl)]
Der Nervenarzt 1981;52(4):211-8.
1981: Reynolds G P; Riederer P
Tranylcypromine isomers in the treatment of Parkinson's disease. Biochemical effects.
International pharmacopsychiatry 1981;16(1):30-3.
1981: Kienzl E; Riederer P; Jellinger K; Wesemann W
Transitional states of central serotonin receptors in Parkinson's disease.
Journal of neural transmission 1981;51(1-2):113-22.
1981: Reynolds G P; Riederer P
The effects of lisuride and some other dopaminergic agonists on receptor binding in human brain.
Journal of neural transmission 1981;51(1-2):107-11.
1980: Reynolds G P; Reynolds L M; Riederer P; Jellinger K; Gabriel E
Dopamine receptors and schizophrenia: drug effect or illness.
Lancet 1980;2(8206):1251.
1980: Jellinger K; Flament H; Riederer P; Schmid H; Ambrozi L
Levodopa in the treatment of (pre) senile dementia.
Mechanisms of ageing and development 1980;14(1-2):253-64.
1980: Reynolds G P; Rausch W D; Riederer P
Effects of tranylcypromine stereoisomers on monamine oxidation in man.
British journal of clinical pharmacology 1980;9(5):521-3.
1980: Riederer P
L-dopa competes with tyrosine and tryptophan for human brain uptake.
Nutrition and metabolism 1980;24(6):417-23.
1980: Riederer P; Birkmayer W; Seemann D; Wuketich S
4-hydroxy-3-methoxyphenylglycol as an index of brain noradrenaline turnover in endogenous depression.
Acta psychiatrica Scandinavica. Supplementum 1980;280():251-7.
1980: Danielczyk W; Riederer P; Seemann D
Benign and malignant types of Parkinson's disease: clinical and patho-physiological characterization.
Journal of neural transmission. Supplementum 1980;(16):199-210.
1980: Reynolds G P; Riederer P; Rausch W D
Dopamine metabolism in human brain: effect of monoamine oxidase inhibition in vitro by (-)deprenyl and (+) and (-) tranylcypromine.
Journal of neural transmission. Supplementum 1980;(16):173-8.
1980: Riederer P; Jellinger K; Kleinberger G; Weiser M
Oral and parenteral nutrition with L-Valine: mode of action.
Nutrition and metabolism 1980;24(4):209-17.
1980: Wuketich S; Riederer P; Jellinger K; Ambrozi L
Quantitative dissection of human brain areas: relevance to transmitter analyses.
Journal of neural transmission. Supplementum 1980;(16):53-67.
1980: Jellinger K; Riederer P; Tomonaga M
Progressive supranuclear palsy: clinico-pathological and biochemical studies.
Journal of neural transmission. Supplementum 1980;(16):111-28.
1979: Riederer P
Regional brain studies on indoles and tyrosine in Mongolian gerbils during nutrition with artificial mixtures high in branched chain amino acids compared to a protein rich diet.
Zeitschrift für Ernährungswissenschaft 1979;18(2):95-103.
1979: Jellinger K; Riederer P; Kothbauer P
[The significance of biogenic amines in cerebral infarction (author's transl)]
Wiener klinische Wochenschrift 1979;91(10):339-44.
1979: Podiwinsky F; Mentasti M; Riederer P; Birkmayer W
[The combined treatment of Parkinson's disease with L-dopa plus decarboxylase inhibitors (carbidopa, benserazide) (author's transl)]
Wiener klinische Wochenschrift 1979;91(10):332-7.
1979: Reynolds G P; Riederer P; Sandler M
2-Phenylethylamine and amphetamine in human brain: effects of L-deprenyl in Parkinson's disease [proceedings]
Biochemical Society transactions 1979;7(1):143-5.
1979: Weiner N; Martin C; Wesemann W; Riederer P
Effects of post-mortem storage on synaptic 5-HT binding and uptake in mammalian brain.
Journal of neural transmission 1979;46(3):253-62.
1979: Birkmayer W; Riederer P; Youdim B H
Distinction between benign and malignant type of Parkinson's disease.
Clinical neurology and neurosurgery 1979;81(3):158-64.
1979: Riederer P; Kleinberger G; Rausch W D; Jellinger K; Wuketich S
[Metabolic factors in the pathogenesis of consciousness disorders and coma]
Klinische Anästhesiologie und Intensivtherapie 1979;19():76-89.
1978: Riederer P; Jellinger K; Rausch W D; Kleinberger G; Kothbauer P
[Biochemistry of hepatic encephalopathy]
Zeitschrift für Gastroenterologie 1978;16(12):768-77.
1978: Jellinger K; Riederer P; Kleinberger G; Wuketich S; Kothbauer P
Brain monoamines in human hepatic encephalopathy.
Acta neuropathologica 1978;43(1-2):63-8.
1978: Jellinger K; Riederer P; Kothbauer P
Brain monoamines in human cerebral infarcts. A preliminary study.
Acta neuropathologica 1978;41(2):173-6.
1978: Reynolds G P; Riederer P; Sandler M; Jellinger K; Seemann D
Amphetamine and 2-phenylethylamine in post-mortem Parkinsonian brain after (-)deprenyl administration.
Journal of neural transmission 1978;43(3-4):271-7.
1978: Riederer P; Youdim M B; Rausch W D; Birkmayer W; Jellinger K; Seemann D
On the mode of action of L-deprenyl in the human central nervous system.
Journal of neural transmission 1978;43(3-4):217-26.
1978: Riederer P; Youdim M B; Birkmayer W; Jellinger K
Monoamine oxidase activity during (--)-deprenil therapy: human brain post-mortem studies.
Advances in biochemical psychopharmacology 1978;19():377-82.
1978: Jellinger K; Riederer P
Brain monoamines in metabolic coma and stroke.
Advances in neurology 1978;20():535-46.
1978: Weiser M; Riederer P; Kleinberger G
Human cerebral free amino acids in hepatic coma.
Journal of neural transmission. Supplementum 1978;(14):95-102.
1978: Riederer P; Rausch W D; Birkmayer W; Jellinger K; Danielczyk W
Dopamine-sensitive adenylate cyclase activity in the caudate nucleus and adrenal medulla in Parkinson's disease and in liver cirrhosis.
Journal of neural transmission. Supplementum 1978;(14):153-61.
1978: Jellinger K; Riederer P; Kothbauer P
Changes of some putative neurotransmitters in human cerebral infarction.
Journal of neural transmission. Supplementum 1978;(14):31-44.
1978: Riederer P; Rausch W D; Birkmayer W; Jellinger K; Seemann D
CNS Modulation of adrenal tyrosine hydroxylase in Parkinson's disease and metabolic encephalopathies.
Journal of neural transmission. Supplementum 1978;(14):121-31.
1978: Jellinger K; Riederer P; Rausch W D; Kothbauer P
Brain monoamines in hepatic encephalopathy and other types of metabolic coma.
Journal of neural transmission. Supplementum 1978;(14):103-20.
1977: Birkmayer W; Riederer P; Ambrozi L; Youdim M B
Implications of combined treatment with 'Madopar' and L-deprenil in Parkinson's disease. A long-term study.
Lancet 1977;1(8009):439-43.
1977: Koppel H; Riederer P
Electrophoresis of unconcentrated natural cerebrospinal fluid.
Journal of neural transmission 1977;41(4):313-8.
1977: Jellinger K; Riederer P
Brain monoamines in metabolic (endotoxic) coma. A preliminary biochemical study in human postmortem material.
Journal of neural transmission 1977;41(4):275-86.
1977: Riederer P; Birkmayer W; Seemann D; Wuketich S
Brain-noradrenaline and 3-methoxy-4-hydroxyphenylglycol in Parkinson's syndrome.
Journal of neural transmission 1977;41(4):241-51.
1976: Ambrozi L; Birkmayer W; Riederer P; Youdim M B
L-dopa and (-)-deprenil in the treatment of Parkinson's disease: a long-term study [proceedings].
British journal of pharmacology 1976;58(3):423P-424P.
1976: Luger A; Pavlik F; Riederer P; Seemann D
[Neurodystrophic quadrant syndrome simulatray puffed-sleeve lipomatosis]
Zeitschrift für Hautkrankheiten 1976;51(7):275-83.
1976: Riederer P; Wuketich S
Time course of nigrostriatal degeneration in parkinson's disease. A detailed study of influential factors in human brain amine analysis.
Journal of neural transmission 1976;38(3-4):277-301.
1976: Bujatti M; Riederer P
Serotonin, noradrenaline, dopamine metabolites in transcendental meditation-technique.
Journal of neural transmission 1976;39(3):257-67.
1975: Neumayer V E; Riederer P; Danielczyk W; Seemann D
[Biochemical findings in the brain in endogenous depression]
Wiener medizinische Wochenschrift (1946) 1975;125(21):344-9.
1975: Birkmayer W; Neumayer E; Riederer P
Proceedings; Biochemistry of circadian rhythm in endogenous depression]
MMW, Münchener medizinische Wochenschrift 1975;117(22):967-8.
1975: Birkmayer W; Riederer P
Biochemical post-mortem findings in depressed patients.
Journal of neural transmission 1975;37(2):95-109.
1975: Birkmayer W; Riederer P
Responsibility of extrastriatal areas for the appearance of psychotic symptoms (clinical and biochemical human post-mortem findings).
Journal of neural transmission 1975;37(2):175-82.
1975: Birkmayer W; Riederer P; Youdim M B; Linauer W
The potentiation of the anti akinetic effect after L-dopa treatment by an inhibitor of MAO-B, Deprenil.
Journal of neural transmission 1975;36(3-4):303-26.
1975: Birkmayer W; Danielczyk W; Neumayer E; Riederer P
Dopaminergic supersensitivity in parkinsonism.
Advances in neurology 1975;9():121-9.
1975: Riederer P; Tenk H; Werner H; Bischko J; Rett A; Krisper H
Manipulation of neurotransmitters by acupuncture (?) (A preliminary communication).
Journal of neural transmission 1975;37(1):81-94.
1974: Birkmayer W; Linauer W; Mentasti M; Riederer P
[2-year experiences with a combination treatment of Parkinsonism with L-dopa and a decarboxylase inhibitor (Benserazid, Ro 4-4602)]
Wiener medizinische Wochenschrift (1946) 1974;124(22):340-4.
1974: Ambrozi L; Riederer P; Birkmayer W; Neumayer E
[Statistical aspects of the tyrosine-tryptophan diagram in depression (author's transl)]
Deutsche medizinische Wochenschrift (1946) 1974;99(20):1087-9.
1974: Birkmayer W; Danielczyk W; Neumayer E; Riederer P
Nucleus ruber and L-dopa psychosis: biochemical post-mortem findings.
Journal of neural transmission 1974;35(2):93-116.
1974: Riederer P; Birkmayer W; Neumayer E; Ambrozi L; Linauer W
The daily rhythm of HVA, VMA, (VA) and 5-HIAA in depression-syndrome.
Journal of neural transmission 1974;35(1):23-45.
1973: Ambrozi L; Birkmayer W; Danielczyk W; Neumayer E; Riederer P
[Biochemical aspects of human behaviour (author's transl)]
Folia clínica internacional 1973;23(9):565-87.
1973: Birkmayer W; Danielcyk W; Neumayer E; Riederer P
L-dopa level in plasma, primary condition for the kinetic effect.
Journal of neural transmission 1973;34(2):133-43.
1973: Riederer P; Birkmayer W; Neumayer E
The tyrosine-tryptophan-diagram in a longtime study with depressed patients.
Journal of neural transmission 1973;34(1):31-48.
1973: Ambrozi L; Birkmayer W; Danielczyk W; Neumayer E; Riederer P
[Biochemical aspects of human behavior]
Wiener Zeitschrift für Nervenheilkunde und deren Grenzgebiete 1973;31(3):191-215.
1972: Birkmayer W; Danielczyk W; Neumayer E; Riederer P
The balance of biogenic amines as condition for normal behaviour.
Journal of neural transmission 1972;33(2):163-78.

Sign-in to see more